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1. Abstract 
Gut commensal microbes shape the mucosal immune system by regulating the 
differentiation and expansion of several types of T cells. Clostridia, a dominant class of 
commensal microbes, can induce colonic regulatory T (Treg) cells, which have a central role 
in the suppression of inflammatory and allergic responses. However, the molecular 
mechanisms by which commensal microbes induce colonic Treg cells are unclear. 
Here, we showed that a large bowel microbial fermentation product, butyrate, a 
short-chain fatty acid, induced the differentiation of colonic Treg cells in mice. A 
comparative NMR-based metabolome analysis suggested that luminal concentrations of 
short-chain fatty acids positively correlated with the number of Treg cells in the colon. 
Butyrate induced the differentiation of Treg cells in vitro and in vivo, and ameliorated the 
development of colitis induced by adoptive transfer of CD4+ CD45RBhi T cells in Rag1−/− 
mice. Treatment of naive T cells with butyrate under Treg-cell-polarizing conditions 
enhanced histone H3 acetylation in the promoter and conserved non-coding sequence regions 
of the Foxp3 locus, suggesting a possible mechanism by which microbial-derived butyrate 
regulates the differentiation of Treg cells. 
In addition, we found that colonization of germ-free mice by gut microbiota induced a 
vigorous proliferation of colonic Treg cells. Global gene expression analysis revealed an 
upregulation of DNA methylation adaptor Uhrf1 in colonic Treg cells in response to bacterial 
colonization. Mice with T cell-specific deletion of Uhrf1 (Cd4creUhrf1fl/fl) were defective in 
colonic Treg cell proliferation and functional maturation. Uhrf1 deficiency de-repressed 
cyclin-dependent kinase inhibitor Cdkn1a due to hypomethylation of its promoter region, 
resulting in Treg cell-cycle arrest. As a consequence, Cd4creUhrf1fl/fl mice spontaneously 
developed severe colitis. Thus, Uhrf1-dependent epigenetic silencing of Cdkn1a is required 
for the maintenance of gut immune homeostasis. This mechanism enforces symbiotic 
host-microbe interactions and contains inflammatory responses. 
Collectively, our findings demonstrate that commensal bacteria-mediated epigenetic 
modification of colonic Treg cells is essential for the maintenance of gut immunological 
homeostasis. 
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2. General introduction 
 
2.1	 Contribution of gut microbiota in the development of the intestinal immune 
system 
The mammalian fetus is maintained under mostly sterile conditions in the uterus. 
However, immediately after birth, it is exposed to a multitude of environmental microbes, 
some of which colonize the skin and mucosal surfaces. In particular, the lumen of the human 
distal intestine contains over 100 trillion bacteria, representing in excess of 1000 species1,2. It 
is estimated that gut microbiota genes in total outnumber our genes by more than 100-fold3. 
Despite such microbial burden in close proximity, the colonizing microbiota seldom causes 
the development of inflammatory disease. Instead, the gut microbiota confers multiple health 
benefits to the host4,5. For example, the gut microbiota ferments indigestible polysaccharides 
ingested to produce biologically active metabolites represented by short-chain fatty acids 
(SCFAs), namely acetate, propionate, and butyrate6,7. Luminal concentrations of total SCFAs 
are about 80–130 mM in the colon8. These metabolites are nutrients for host cells such as 
intestinal epithelial cells (IECs)9, which cover the mucosal surface of the gastrointestinal 
tract10. The gut microbiota also has the ability to convert primary bile acids synthesized in the 
liver into secondary bile acids, via dehydration reactions, which play an important role in the 
regulation of digestion5. Furthermore, some commensal bacterial strains have enzymes 
necessary for the biosynthesis of vitamins, which are essential for the maintenance of 
mammalian health11. These findings indicate that the gut microbiota intimately influences the 
metabolism of their hosts and critically contributes to mammalian physiology and health4. 
Compelling evidence suggests that colonization by the gut microbiota is essential for 
the development and regulation of the intestinal immune system, which consists of three 
major compartments: intestinal epithelial barrier10, gut-associated lymphoid tissues (GALT)12 
and immune cells in the intestinal lamina propria (LP)13. Commensal bacteria and their 
products facilitate the production of antimicrobial peptides (AMP) by IECs14, the formation 
of a physical barrier15-19, and the gut epithelial turnover20. The mice housed in germ-free 
isolator (germ-free mice) are more susceptible to epithelial destruction compared with 
conventionally raised mice21,22. The presence of gut microbiota is also essential for the 
maturation of GALT, namely Peyer’s patches (PPs), and isolated lymphoid follicles (ILF), 
which play a pivotal role in the induction of immunoglobulin A (IgA) responses23 and in the 
regulation of oral tolerance24. Furthermore, accumulating data have demonstrated the 
essential role of gut microbiota in the regulation of immune responses in the intestinal LP. 
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For example, segmented filamentous bacteria (SFB), indigenous to mouse small intestine, 
facilitate the differentiation of intestinal type 17 helper T (TH17) cells25. TH17 cells play an 
important role in host defense against infection by recruiting neutrophils and macrophages to 
infected tissues and are associated with the pathogenesis of autoimmune diseases26. On the 
other hand, Clostridium species have been reported to promote the induction of colonic 
regulatory T (Treg) cells27,28, which play a central role in the suppression of the inflammatory 
and allergic immune responses29. In support of this notion, the frequency of TH17 and Treg 
cells is remarkably low in germ-free mice25,27. Furthermore, it is conceivable that insufficient 
microbial exposure causes an imbalance in immune responses, leading to the development of 
allergy and inflammatory bowel disease (IBD)30. Indeed, under GF conditions, systemic 
immune responses are biased towards TH2, which is associated with allergic response and 
corresponding elevated serum IgE. Such an immunological phenotype of GF mice is 
normalized by exposure to diverse microbiota during early life31. This finding provides an 
experimental evidence for the “hygiene hypothesis”32. These previous observations raised the 
notion that host-microbe interactions maintain the immunological homeostasis in the gut. 
Nevertheless, these phenomenological findings explain only partially the molecular 
mechanisms behind the influence of gut microbiota on intestinal immune homeostasis. 
 
2.2 Regulation of intestinal helper T (TH) cell responses by the gut microbiota  
As described earlier, several studies have shown that the gut microbiota has an 
important role in balancing intestinal TH cell responses33. Colonization of GF mice with 
Bacteroides fragilis, a gut-indigenous gram-negative bacterium, polarizes splenic CD4+ T 
cells toward TH1 cells34. In the gut, polysaccharide A (PSA) produced by B. fragilis increases 
IL-10 production by Treg cells and reciprocally inhibits TH17 responses through binding to 
TLR2 expressed on Treg cells, and eventually prevent experimental colitis induced by 
colonization with Helicobacter hepaticus35,36.  
Colonization by SFB facilitates intestinal TH17 differentiation in a TLR 
signaling-independent manner, since the intestinal TH17 population was comparable between 
WT and MyD88/TRIF double knockout mice. This event was also found to be independent of 
NOD-RIP2 signaling25. Of note, SFB-dependent upregulation of serum amyloid A (SAA) 
plays a critical role in the induction of intestinal TH17 cells25. Recently, Goto et al. reported 
that SFB antigen presentation by DCs through MHC class II-dependent pathway is important 
for the induction of TH17 cells; although, presentation of the same antigen by group 3 innate 
lymphoid cells (ILC3) negatively regulates TH17 differentiation37. While SFB is a potent 
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inducer of TH17 cells in the ileum, colonic TH17 cells are induced by gut microbiota-derived 
ATP38. Colonic CD70+ DCs that express the ATP-sensing receptors P2X and P2Y 
preferentially induce the differentiation of naïve T cells into TH17 cells38. However, several 
questions remain regarding which bacterial strains release ATP, as well as the mechanism by 
which DCs recognize its presence across the epithelial barrier33.  
Intestinal Treg cells critically contribute to prevent aberrant immune response to the 
gut microbiota27,29. Treg cells are currently classified into thymus-derived Treg (tTreg) and 
peripherally-induced Treg (pTreg) cells, according to their origin39. Thymus-derived Treg 
and pTreg cells can be distinguished by the differential expression of Helios40 and 
neuropilin1 (Nrp1), with low to undetectable expression of these markers present in pTreg 
cells41,42. The number of colonic Treg cells is dramatically decreased in germ-free mice as 
compared to conventionally raised mice27. Importantly, there is a striking reduction in the 
Helios−Neuropilin1−Foxp3+ population, which can be rescued by the inoculation of fecal 
bacteria from conventional mice. The same is true in mammalian newborns. Colonization by 
commensal bacteria promotes the induction, migration, and proliferation of colonic Treg 
cells43,44. Consequently, the percentage of Treg cells among total colonic CD4+ T cells 
rapidly increases during infancy. This microbiota-dependent Treg expansion is apparently 
confined to the colonic LP, and it does not extend to systemic lymphoid tissues, including the 
spleen. These observations suggest that bacterial colonization is a key determinant for the 
development of Treg cells in the gut. Several studies have identified the bacterial strains 
responsible for the development of functional Treg cells in the colonic LP. Atarashi et al. 
reported that the exposure to a cocktail of 46 Clostridium strains belonging to clusters IV and 
XIVa is sufficient to promote the differentiation of colonic pTreg cells in GF mice27. Oral 
inoculation with feces isolated from 46 strain-associated gnotobiotic mice into infant specific 
pathogen-free (SPF) mice inhibits ovalbumin (OVA)-induced IgE responses and symptoms 
of DSS-induced colitis by promoting the induction of colonic Treg cells. Of note, reduction 
in abundance of Clostridiales cluster IV and XIVa species (e.g. Clostridium leptum and 
Clostridium coccoides, respectively) in the gut has been associated with the development of 
human IBD. Consistent with these reports, a mixture of 17 strains from Clostridiales clusters 
VI, XIVa, and XVIII isolated from human feces also exhibits this Treg-inducing capability28. 
This observation raises the possibility that these bacterial species may contribute to the 
maintenance of gut immunological homeostasis in humans.  
Inoculation of GF mice with altered Schaedler flora (ASF) promotes the activation 
and de novo generation of Treg cells in the colon, and reciprocally suppresses TH1 and TH17 
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responses45. Germ-free mice have a larger cecum because of the accumulation of hydrated 
dietary fiber components. ASF is a defined set of benign intestinal commensal microbiota 
composed of 8 bacterial species, which have been selected to normalize the size and volume 
of cecum in germ-free mice. The bacterial community in ASF-colonized mice actively 
undergoes microbial fermentation to produce small-molecule metabolites. This finding leads 
us to speculate that gut microbiota-derived metabolites could contribute the induction of 
colonic Treg cells.  
 
2.3 Epigenetic regulation of the immune system 
Epigenetic regulation including DNA methylation and histone modification is a 
heritable modification that influences gene expression46. DNA and histone chemical 
modifications induce conformational changes in chromatin structures towards one of two 
fundamental states: open chromatin permissive for gene transcription, and closed chromatin 
to repress gene expression. Modifications on the amino-terminal tail of histones include 
acetylation, methylation, phosphorylation, and ubiquitylation. Among them, acetylation 
neutralizes the cationic charge of histones, which is important to tightly bind DNA. As such, 
histone tail acetylation eventually generates an open chromatin state33. On the other hand, 
DNA methylation is associated with alterations in chromatin structure and transcription. In 
particular, cytosine methylation within CpG islands in promoter regions correlates with gene 
silencing, and thus utilized as repressive marker. DNA methylation is mediated by the DNA 
methyltransferase (Dnmt) family of enzymes, of which Dnmt1 contribute to maintain DNA 
methylation during DNA replication46. Uhrf1 (Ubiquitin-like, with PHD and RING finger 
domains 1) plays a non-redundant role in the maintenance of DNA methylation by 
recognizing and recruiting Dnmt1 to hemi-methylated DNA in proliferating cells77,78. 
Compelling evidence has suggested that DNA methylation and histone H3 
acetylation/tri-methylation within promoters and/or regulatory elements of genes encoding 
key transcription factors and effector molecules play pivotal roles in the cell-fate decision and 
functional maturation of T cells47,48. Moreover, memory T cells also maintain epigenetic 
marks similar to those in effector T cells, enabling them to rapidly exert a secondary response 
upon re-encounter with antigens by recruiting RNA polymerase II to open chromatin 
surrounding cytokine-encoding genes. Thus, effector genes in memory T cells are kept under 
a poised transcriptional state33,47.  
Furthermore, epigenetic modifications are also closely associated with cell fate 
decisions and cell lineage stabilization during the development of Treg cells. The 
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differentiation and function of Treg cells are primarily controlled by master transcription 
factor Foxp3. Foxp3 expression is regulated by its promoter as well as by intragenic enhancer 
elements, termed conserved non-coding sequence 1–3 (CNS1–3). CNS1 and CNS3 are 
essential for de novo Foxp3 expression, whereas CNS2 contributes to the maintenance of 
Foxp3 expression49,50. Notably, the CNS1 region, known as the “TGF-β sensor,” has binding 
elements for Smad3, RAR, and NFAT, and is activated by TGF-β, retinoic acids, and T-cell 
receptor (TCR) stimulation, respectively. These stimuli are required for Foxp3 induction. In 
addition, CNS3 possesses a c-Rel-binding element that is responsive to signals emanating 
from TCR and co-stimulatory receptors49. Furthermore, the histone acetylation status of the 
promoter and CNS regions is positively correlated with expression of Foxp3. These 
observations show the importance of epigenetic regulation in the maintenance of Treg 
homeostasis.  
Several studies have shown that certain infectious agents as well as commensal 
bacteria can change the epigenetic status of mammalian host cells during infection and 
symbiosis51-56. In addition, we observed that colonic Treg development was positively 
correlated with an increase in luminal concentrations of SCFAs produced by commensal 
bacteria. Importantly, it is well known that SCFAs epigenetically regulate gene expression by 
inhibiting histone deacetylase (HDAC) activity. Based on these observations, we 
hypothesized that the gut microbiota may induce colonic Treg cells via epigenetic 
modifications by the action of metabolites that it produces. In this study, we investigated the 
biological significance of microbe-derived SCFAs in the intestinal immune system by taking 
advantage of acylated resistant starches that enabled us to efficiently deliver SCFAs to the 
distal intestine. We also explored the molecular mechanisms by which SCFAs exert an 
immune modulatory effect. Furthermore, to examine the effect of bacterial colonization on 
colonic Treg induction during early life, we performed a transcriptome analysis of colonic T 
cells from germ-free and bacteria colonized ex-germ-free mice.  
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3. Results 
3.1 Section I: Commensal microbe-derived butyrate induces colonic 
regulatory T cells  
(Published in Nature 504, 446–450. 19th December, 2013. doi:10.1038/nature12721) 
 
Contribution of intestinal fermentation in the generation of colonic Treg cells 
Germ-free mice have an enlarged caecum because of the accumulation of hydrated 
dietary fibre components. Colonization with chloroform-resistant bacteria (CRB)57 
normalizes caecal size, probably through fermentation of these components by the CRB (Fig. 
1-1 a, b). Therefore, CRB-derived dietary fibre metabolites could be responsible for the 
induction of colonic Treg cells. To assess this possibility, CRB-associated mice were fed 
either a low-fibre diet (LFD) or a high-fibre diet (HFD). In CRB-associated HFD-fed 
(CRB-HFD) mice, the expression of neuropilin-1− and Helios− (also known as IKZF2−) Treg 
cells, which represent the peripherally generated Treg cell population40-42, was significantly 
increased (Fig. 1-1 c, d and Figs. 1-2, 1-3). Consistent with previous observations3, the effect 
of CRB on Treg cell induction was restricted to the colon and not the mesenteric lymph 
nodes or spleen (Fig. 1-4). In addition, the expression of CD103+-activated Treg cells was 
also increased in CRB-HFD mice (Fig. 1-1d). Notably, a LFD compromised the effects of 
CRB colonization on Treg cell induction (Fig. 1-1 c, d), despite the comparable number and 
composition of gut microbes predominantly annotated as Clostridiales (Figs. 1-5, 1-6, 1-7). 
These observations strongly suggest that metabolic differences in gut microbes are 
responsible for the differential Treg cell inducibility between CRB-HFD and CRB-LFD 
mice. 
 
Identification of metabolites responsible for the Treg induction 
To explore the metabolite(s) that has a biological activity to induce Treg cells, we 
performed a NMR-based metabolome analysis. Principal component analysis (PCA) and 
orthogonal partial least squares discriminate analysis of the metabolome data indicated that 
the amount of caecal short-chain fatty acids (SCFAs), namely acetate, propionate and 
butyrate, was higher in CRB-HFD than in CRB-LFD mice (Fig. 1-1 e, f and Fig. 1-8 and 
Table 1-1). Quantitative analysis confirmed a significant increase in acetate and butyrate in 
the caecal content and colonic tissues of CRB-HFD mice (Fig. 1-1 g, h). Luminal 
GABA (g-aminobutyric acid), l-leucine and l-isoleucine were also increased in CRB-HFD 
mice (Fig. 1-1f and Fig. 1-8). To test whether these metabolites can induce Treg cells in vitro, 
Epigenetic modifications and immune regulation by gut microbiota 
Yuuki OBATA 
 
 11 
splenic naive (CD44lo CD62Lhi) CD4+ T cells were cultured in the presence of T-cell antigen 
receptor and CD28 signalling plus TGF-b with or without each metabolite. Butyrate 
significantly increased the frequency of Foxp3+ cells (Fig 1-9 a, b). Propionate showed a 
moderate effect, whereas the other metabolites, including acetate, did not have any effect on 
Treg cell induction at physiological concentrations (Fig. 1-9 a, b and Fig. 1-10). 
 
Butyrate induces the differentiation of functional Treg cells in the colon 
To corroborate the role of butyrate in Treg cell induction in vivo, specific 
pathogen-free (SPF) C57BL/6 mice were fed modified diets containing acetylated, 
propionylated or butyrylated high-amylose maize starches58 (HAMSA, HAMSP or HAMSB, 
respectively) to increase the luminal levels of the corresponding SCFA (Fig. 1-9c). 
Consistent with the in vitro observations, colonic Treg cells were significantly augmented 
when the diet contained HAMSB, whereas HAMSP slightly and HAMSA barely induced 
Treg cells in SPF mice (Fig. 1-9 d, e and Fig. 1-11). The HAMSB diet also increased the 
number of ovalbumin (OVA)-specific colonic OT-II Foxp3+ cells from adoptively transferred 
OT-II naive CD4+ T cells (Fig. 1-9 f, g). Because butyrate did not affect the survival or the 
proliferation of colonic Treg cells (Figs 1-12 and 1-13), this increase probably reflects a role 
for this SCFA in regulating Treg cell differentiation. Furthermore, the intake of HAMSB 
increased colonic Treg cells in germ-free mice mono-associated with Bacteroides 
thetaiotaomicron, an organism devoid of butyrate-producing and Treg-cell-inducing activities 
per se3 (Fig. 1-14). Under germ-free conditions, HAMSB did not increase Treg cells, 
suggesting that the presence of commensal bacteria is a prerequisite for Treg cell induction 
(Fig. 1-15). 
Interleukin (IL)-10 production by Treg cells is well documented to be required for 
containment of inflammatory responses in mucosal tissues including the colon59, and the 
colonization with a mixture of Clostridiales is sufficient to induce IL-10-producing Treg 
cells27. Likewise, the intake of HAMSB significantly increased IL-10-producing Treg cells in 
the colon (Fig. 1-9h). Collectively, these observations illustrate that butyrate has a key role in 
the commensal-microbe-mediated differentiation of functional Treg cells in the colon. 
We also explored the effect of butyrate on the differentiation of naive T cells into 
other CD4+ T-cell subsets. Treatment with butyrate or feeding of HAMSB did not affect the 
induction of T-bet, GATA3 and RORgt, the master regulators of T helper 1 (TH1), TH2 and 
TH17 cells, respectively (Figs 1-16 and 1-17). Notably, butyrate promoted the induction of 
Foxp3+ cells even under TH1- and TH17-polarizing conditions. These data strongly suggest 
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that butyrate preferentially induces Treg cell differentiation. 
The requirement for the Toll-like receptor (TLR)–MyD88 signalling pathway22 in 
commensal microbe-induced Treg cell expansion seems to be variable depending on the type 
of bacteria involved27,45,60. We observed that treatment of SPF Myd88−/− Ticam1−/− mice with 
HAMSB induced colonic Treg cells (Fig. 1-18) to the same extent as in wild-type mice (Fig. 
1-9 d, e). Therefore, TLR–MyD88 signalling is dispensable for butyrate-dependent Treg cell 
induction in the colon. 
 
Histone modification at the Foxp3 locus by butyrate 
Butyrate is well known to regulate gene expression epigenetically by inhibiting histone 
deacetylases (HDACs) 61,62, specifically classes IIa and I of the four HDAC classes identified 
in mammals. Because class IIa HDAC has been reported to suppress Treg cell expansion63,64, 
butyrate may influence histone acetylation of gut CD4+ T cells to regulate epigenetically the 
transcription of the genes responsible for Treg cell induction. To verify this hypothesis, we 
performed chromatin immunoprecipitation sequencing (ChIP-seq) analysis of naive CD4+ T 
cells treated with or without butyrate under Treg-cell-polarizing conditions. Butyrate slightly 
increased genome-wide histone H3 acetylation (Fig. 1-19). Consistently, the histone 
acetylation status of the promoter regions of most transcription factors was unchanged or 
moderately upregulated (Fig. 1-20 a–c), and only 70 transcription factors (4.73% of the genes 
categorized as a transcription factor), including Foxp3, were highly acetylated after butyrate 
exposure (Fig. 1-20b, pink area). Importantly, this increased histone acetylation was 
positively correlated with gene expression (Fig. 1-20c). Foxp3 expression is regulated not 
only by its promoter but also by intragenic enhancer elements termed conserved noncoding 
sequence (CNS) 1–365. Butyrate upregulated histone H3 acetylation at both the promoter and 
CNS3 of the Foxp3 gene locus 1 day before Foxp3 induction (Fig. 1-20 a, d). Furthermore, 
butyrate exposure gradually increased the acetylated histone H3 status of the CNS1 region 
over the course of Treg cell differentiation. In sharp contrast, no such epigenetic 
modifications were observed in the Tbx21, Gata3 and Rorc genes after butyrate exposure 
(Fig. 1-21). CNS1, which contains binding motifs for Smad3, NFAT and retinoic acid 
receptor, is important for the peripheral induction of Foxp365. Conversely, CNS3 contains a 
c-Rel binding motif, which establishes the Foxp3-specific enhanceosome and thus greatly 
enhances the probability of Foxp3 induction49,66. We detected little, if any, increase in histone 
H3 acetylation at the c-Rel, NFAT, Smad3 or Stat5 promoters after butyrate exposure (Fig. 
1-22). Correspondingly, expression levels of these genes remained unchanged (Fig. 1-23). On 
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the basis of these observations, we propose that butyrate probably augments the accessibility 
of these transcriptional regulators to the enhancer elements as well as the promoter region 
through acetylation of the Foxp3 gene locus. 
 
Physiological significance of butyrate in the maintenance of gut immune homeostasis 
Finally, we investigated the function of the butyrate-induced Treg cells in chronic 
intestinal inflammation by adoptively transferring CD4+ CD45RBhi naive T cells into Rag1−/− 
mice67. Over the course of the experiment, the recipient mice were fed either a control 
HAMS- or a HAMSB-containing diet. The HAMS-fed group developed wasting disease in 
association with severe colitis. However, the intake of HAMSB, but not HAMSA or HAMSP, 
ameliorated the colitis development (Fig. 1-24 a–f and Fig. 1-25). This beneficial effect is at 
least partly attributed to the induction of colonic Treg cells by butyrate. In support of this 
notion, depletion of Treg cells abrogated the protective effect of HAMSB (Fig. 1-24 g–k). 
The present study demonstrates that butyrate produced by gut microbes induces 
functional colonic Treg cells, specifically among CD4+ T-cell subsets, via T-cell intrinsic 
epigenetic upregulation of the Foxp3 gene. However, we do not formally exclude the 
possibility that effects of butyrate other than histone acetylation status, or targets of HDAC 
other than histones, may also be involved in Treg cell differentiation. SCFAs have also been 
reported to act through cell surface signalling receptors such as G-protein-coupled receptor 
43 (GPR43) to execute some of their functions68; however, this is unlikely to be the case for 
the effect of butyrate on Treg cells, because acetate, which is a potent GPR43 ligand69, failed 
to ameliorate T-cell-dependent experimental colitis or induce Treg cell differentiation (Fig. 
1-9 a–e and Fig. 1-25). In addition, the expression of GPR43 is restricted to myeloid cells 
among haematopoietic cell lineages. Nevertheless, we do not exclude the possibility that 
butyrate may stimulate other GPRs on myeloid cells including dendritic cells to facilitate 
Treg cell differentiation. 
Butyrate has been appreciated for its beneficial effects on the host, including trophic 
and anti-inflammatory effects on epithelial cells70. The butyrate transporter is downregulated 
in the colonic mucosa of patients with inflammatory bowel diseases (IBD)71. In addition, 
butyrate-producing bacteria are decreased in the intestinal microbiota at the gut mucosa and 
in the faecal samples of patients with IBD compared to control patients72. These facts suggest 
that butyrate insufficiency may be involved in the pathogenesis of IBD. In support of this 
idea, butyrate enema, alone or as a cocktail of SCFAs, has been shown to ameliorate colonic 
inflammation in patient with IBD73,74, although the underlying mechanisms were not fully 
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understood. Our findings not only link butyrate to commensal microbe-mediated induction of 
functional Treg cells in the colonic mucosa, but also provide molecular insight into the 
therapeutic application of butyrate and how a metabolite produced by colonic microbial 
fermentation mediates host–microbial crosstalk for establishment of gut immune homeostasis 
(Fig. 1-26). 
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3.2 Section II: Colonic microbe induce Uhrf1-dependent functional 
expansion of colonic Treg cells 
(Published in Nature Immunology 15, 571–579. 28th April, 2014. doi:10.1038/ni.2886) 
 
Gut bacteria induce proliferation of colonic Treg cells  
Colonization of gut microbiota induces not only the differentiation but also the 
proliferation of colonic Treg cells after birth28. On the other hand, commensal 
bacteria-derived butyrate did not promote the proliferation of Treg cells44. These observations 
lead us to speculate that there are other mechanisms that facilitate the proliferation of colonic 
Treg cells. To gain mechanistic insight into the induction of colonic Treg proliferation, we 
orally inoculated commensal microbiota into germ-free (GF) mice and monitored changes in 
IL-2-expressing CD4+ T cells and Foxp3+ Treg populations in the colonic lamina propria (cLP) 
of these ex-germ-free (exGF) mice. The frequency of IL-2+CD4+ T cells peaked within 3 days 
after bacterial colonization, and then gradually decreased to basal amounts at day 7 (Fig. 2-1a, 
blue line). The kinetics of Treg expansion paralleled that of the IL-2+CD4+ T cells up until day 3, 
but then the Treg cells continued to expand (Fig. 2-1a, black line), becoming the dominant CD4+ 
T cell population in the colon. The rapid expansion of Treg cells after bacterial colonization 
raised the possibility that the commensals may induce not just differentiation44,75 and migration43 
but also local proliferation of Treg cells in the cLP. Indeed, Ki67+ proliferative Treg cells were 
remarkably increased after bacterial colonization (Fig. 2-1a, red line). Proliferating (EdU+) Treg 
cells were much more abundant in the cLP of exGF mice compared to GF mice (Fig. 2-1b, upper 
panels). Differential expression of neuropilin1 (Nrp1) has been proposed as a marker to 
distinguish natural and peripherally induced Treg subsets41,42. We observed that both Nrp1– 
(pTreg cells) and Nrp1+ (tTreg cells) Foxp3+ subsets displayed the proliferative response, 
although it was more prominent in the Nrp1– population (Fig. 2-1c). This proliferative response 
was confined to colonic Treg cells, but not CD4+Foxp3- conventional T (Tconv) cells or splenic 
CD4+ T cell subsets (Fig. 2-1b, lower panels and Fig. 2-2a). Similarly, the rapid Treg expansion 
was observed in the cLP, but not spleen, of SPF mice before weaning, a time during which 
the intestinal microflora is established (Fig. 2-2 b, c). To gain further evidence that the 
proliferation of Treg cells was occurring locally in the colon, we blocked influx of extraintestinal 
Treg cells with neutralizing antibodies against α4β7 integrin subunits43 prior to the administration 
of EdU to exGF mice. This treatment only marginally affected the abundance of proliferative 
Treg cells in the colon (Fig. 2-1d). Collectively, these results suggest that colonization by 
commensal bacteria induces extensive proliferation of Treg cells primarily within the colonic 
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mucosa. 
  
IL-2 is responsible for the colonic Treg expansion 
IL-2 is well documented to promote Treg proliferation76 and is induced in the colonic 
mucosa, particularly in CD4+ T cells after bacterial inoculation (Fig. 2-1a). Similarly, colonic 
CD4+ T cells express high amounts of IL-2 in SPF-housed infant mice (around 2-weeks-old), 
during which Treg cells display active proliferation in the cLP but not spleen (Fig. 2-2 b, d). 
We therefore postulated that the early IL-2 induction may be responsible for the local 
proliferation of Treg cells. To test this idea, we treated exGF mice with anti-IL-2 neutralizing 
antibody after the inoculation of commensal bacteria. As expected, abrogation of IL-2 strongly 
suppressed the induction of colonic Treg cells (Fig. 2-3a). EdU+ proliferating Treg cells were 
also significantly decreased in the antibody-treated exGF mice (Fig. 2-3b). On the basis of these 
observations, we reasoned that an early IL-2 response is indispensable for the proliferation of 
Treg cells within the colon.  
 
IL-2 upregulates Uhrf1 in colonic Treg cells    
We explored the molecular machinery that mediates colonic Treg proliferation. First, we 
profiled genes selectively upregulated in Treg cells from exGF mice (Cluster I, Fig. 2-4a). We 
also categorized IL-2-responsive molecules (Cluster II, Fig. 2-4b). After comparison of the two 
clusters followed by gene ontology-based function analysis, we selected several candidate genes 
that are potentially associated with the proliferation of colonic Treg cells in an IL-2-dependent 
manner (Fig. 2-4c). Among those specifically upregulated in colonic Treg cells was the DNA 
methyltransferase adapter Uhrf1 (Fig. 2-4d). Uhrf1 (Ubiquitin-like, with PHD and RING finger 
domains 1), also known as Np95 in mouse and ICBP90 in human, is an epigenetic regulator that 
forms gene-repression complexes through its interaction with DNA methyltransferase1 (Dnmt1) 
and histone deacetylase 177-80. Uhrf1 preferentially binds hemi-methylated DNA via the SET and 
RING finger-associated (SRA) domain, and significantly contributes to accurate maintenance of 
DNA methylation by recruiting Dnmt1 to the hemi-methylation sites. Therefore, ablation of 
Uhrf1 results in hypomethylation of retrotransposons and imprinted genes in embryonic stem 
cells78.  
Uhrf1 expression was highest in Treg cells among colonic CD4+ T cell subsets in SPF 
mice (Fig. 2-4e). We confirmed that IL-2 is essential for Uhrf1 expression by colonic Treg cells 
after inoculation of commensals, since neutralization of IL-2 in exGF mice significantly inhibited 
the Uhrf1 expression (Fig. 2-4f). In contrast, Uhrf1 was not induced in the splenic Treg cells 
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from exGF mice (Fig. 2-2e). Consistent with our observations in exGF mice, Uhrf1 was highly 
upregulated in colonic Treg cells during the expansion phase in infant SPF mice (Fig. 2-2c).  
To rigorously confirm the role of bacterial colonization in Uhrf1 expression, we analyzed 
gnotobiotic mice associated with the 17-strain mixture of Clostridia (17-mix), which efficiently 
induces Treg expansion in the colon28. Inoculation of GF mice with the 17-mix significantly 
augmented IL-2 expression by Tconv cells (Fig. 2-4g), leading to upregulation of Uhrf1 in Treg 
cells, with a concomitant increase in their proliferation (Fig. 2-4 h, i). We also confirmed 
upregulation of Uhrf1 in cultured Treg cells simulated with IL-2 (Fig. 2-4j), in which 
accumulation of Stat5 on the promoter region of the Uhrf1 gene was also evident (Fig. 2-4k). 
Together, these results indicate that commensal bacteria upregulate Uhrf1 in Treg cells by 
eliciting IL-2 production from Teff cells in the colonic mucosa.   
 
Uhrf1 is critical for colonic Treg proliferation 
To interrogate the role of Uhrf1 in colonic Treg homeostasis, we generated 
Cd4creUhrf1fl/fl mice (Fig. 2-5a), and crossed them to Foxp3hCD2 reporter mice81 (denoted in the 
figures as ‘fl/fl’). In young Cd4creUhrf1fl/fl mice reared under SPF conditions, the overall 
composition of B and T lymphocytes was intact (Fig. 2-5 b, c). However, these mice had a 
severe defect in the development of colonic Treg cells indicative of the importance of Uhrf1 in 
Treg cell homeostasis in the colonic mucosa (Fig. 2-6a). A slight if any decrease in Treg cells 
was observed in the spleen and thymus of Cd4creUhrf1fl/fl mice (Fig. 2-5d). The reduction of 
colonic Treg cells was also confirmed in mixed bone marrow chimeras containing 
Uhrf1-deficient and congenic wild-type progenitors. Treg cells derived from the bone marrow 
(BM) of Uhrf1-deficient mice were nearly absent in the BM chimeras (Fig. 2-7 a-c). Thus, a 
Treg cell-intrinsic defect is the cause of the reduction. Collectively, these data demonstrate that 
Uhrf1 is essential for the maintenance of colonic Treg cells but not extra-colonic Treg cells. 
We further examined whether Uhrf1 deficiency affects differentiation or proliferation of 
Treg cells by both in vitro and in vivo experiments. Uhrf1 deficiency did not influence Treg 
differentiation and the stability of Foxp3 expression in an in vitro culture system (Fig. 2-6b and 
data not shown). To rigorously confirm this interpretation, naive CD4+ T cells were transferred 
from Uhrf1-deficient or Uhrf1-sufficient CD45.2+ mice into CD45.1+ mice. The efficiency of in 
vivo Treg differentiation was comparable between Uhrf1-deficient and Uhrf1-sufficient naive T 
cells (Fig. 2-8 a, b). On the other hand, Uhrf1 deficiency severely affected cell proliferation due 
to cell cycle arrest at the G1-S transition (Fig. 2-6 c, d). The same was true in Uhrf1-deficient 
Treg cells in cLP, because the frequency of Ki67+ proliferating Foxp3+ Treg cells was reduced to 
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one-third in the colon of Cd4creUhrf1fl/fl mice compared to that in littermate controls (Fig. 2-6 e, 
f). In sharp contrast, proliferation of Tconv cells was unaffected by Uhrf1 deficiency (Fig. 2-6e). 
The role of Uhrf1 in Treg homeostasis was further corroborated by another in vivo experiment. 
Although there was no difference in the proportion of Treg cells between Uhrf1-deficent and 
Uhrf1-sufficient mice under GF conditions (Fig. 2-6g), Uhrf1-deficient mice were defective in 
Treg expansion in response to colonization by chloroform-resistant bacteria (CRB), which consist 
of spore-forming bacteria mainly annotated as Clostridia class bacteria27,57 (Fig. 2-6h). Thus, 
Uhrf1 is indispensable for the local expansion of colonic Treg cells.  
Considering that Uhrf1 is an IL-2 responsive gene, the IL-2-Uhrf1 axis may play a key 
role in extensive Treg proliferation. To further investigate this possibility, we treated 
Uhrf1-deficient and Uhrf1-sufficient mice with exogenous IL-2 mixed with an anti-IL-2 
monoclonal antibody (mAb) i.e. as an IL-2 complex. Consistent with a previous report82, this 
treatment potently induced a proliferative response in the systemic Treg population; however, this 
response was strongly attenuated in the same population of Uhrf1-deficient mice (Fig. 2-6i). The 
IL-2-IL-2 mAb complex also induced proliferation of Tconv cells, albeit to a lesser extent than in 
Treg cells, regardless of the presence of Uhrf1. These data provide evidence for the significant 
role of the IL-2-Uhrf1 axis in Treg proliferation but a lesser role for Tconv cells. 
Cell proliferation may confer functional maturity to Treg cells83, as evidenced by 
upregulation of functional molecules in the proliferative compartment (Fig. 2-9a). We 
hypothesized that reduced proliferative activity in the absence of Uhrf1 may affect the 
suppressive activity of Treg cells. Indeed, ablation of Uhrf1 impaired expression of functional 
molecules including IL-10 and CTLA-4 (Fig. 2-6j and Fig. 2-9b). Accordingly, Uhrf1-deficient 
Treg exhibited attenuated immunosuppressive function, and failed to prevent the development of 
experimental colitis (Fig. 2-10). Based on these observations, we conclude that Uhrf1 plays an 
essential role in the functional maturation of Treg cells within the colonic mucosa, likely by 
regulating cell proliferation. 
 
Uhrf1 epigenetically represses Cdkn1a expression 
The Uhrf1-Dnmt1 complex plays a critical role in the accurate maintenance of DNA 
methylation, which contributes to gene repression77,78. To define the Uhrf1 target molecule(s) 
involved in Treg proliferation, we first profiled the gene subset specifically de-repressed only in 
Treg cells (Fig. 2-11a). Gene-function-enrichment analysis of the profiled genes identified a 
group of genes termed ‘cellular growth and proliferation’ at the top of the list (Fig. 2-11 b, c). 
Furthermore, using our integrated omics approach with the datasets obtained from the 
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transcriptome and methylated DNA-precipitation-sequencing (MeDP-seq)-based methylome 
analysis (Fig. 2-12a), we could identify Cdkn1a as a Uhrf1 target molecule (Fig. 2-12b). Cdkn1a 
is a cell cycle regulator that induces cell cycle arrest at the G1-S transition84. We confirmed a 
substantially increased Cdkn1a mRNA and Cdkn1a protein in Uhrf1-deficient Treg cells (Fig. 
2-12 c, d). The de-repression of Cdkn1a most likely resulted from CpG hypomethylation of the 
distal promoter region in the absence of Uhrf1 (Fig. 2-12e, arrowheads and f-g), an outcome that 
was more prominent in Treg than in Tconv cells. To further explore whether the de-repression of 
Cdkn1a causes the cell cycle arrest in Uhrf1-deficient Treg cells, we treated in vitro induced 
Uhrf1-deficient Treg cells with siRNA targeting Cdkn1a, and analyzed their cell cycle status. The 
knockdown of Cdkn1a at least partially rescued the G1 arrest, as indicated by an increase in the 
ratio of S and G2-M phases (Fig. 2-12h). From these data, we concluded that Uhrf1-dependent 
repression of Cdkn1a is critical for the maintenance of Treg proliferation. 
  
Uhrf1-deficient mice spontaneously develop colitis 
Intestinal Treg cells orchestrate the immunoregulatory system that suppresses 
inappropriate immune responses to commensal bacteria67. Given that its absence leads to a 
serious defect in the accumulation of colonic Treg cells, Uhrf1 may be fundamental to the 
maintenance of intestinal immune homeostasis. In support of this notion, Uhrf1-deficient mice 
spontaneously developed colitis characterized by thickening of the colonic wall, epithelial 
hyperplasia, loss of goblet cells and massive cellular infiltrates into the colonic mucosa and 
submucosa before 10 weeks of age (Fig. 2-13 a-d and Fig. 2-14a). Nearly all of the mice 
eventually succumbed to death within 6 months due to the exacerbated colitis. By contrast, 
there were no inflammatory symptoms in the other peripheral tissues examined including liver, 
kidney, lung, skin, pancreas, stomach, salivary gland and small intestine (Fig. 2-15), consistent 
with the observation that Uhrf1-regulated Treg expansion occurs principally in the local 
colonic mucosa (Figs. 2-1, 2-2, 2-3, 2-4, 2-5 and 2-6). Commensal bacteria are the causative 
agent of this chronic inflammatory response, because Cd4creUhrf1fl/fl mice raised under GF 
conditions did not display any inflammation (Fig. 2-14 b-d). 
We subsequently examined the immunological phenotype of the spontaneous colitis. 
Transcripts of proinflammatory cytokine genes were remarkably upregulated in 
Cd4creUhrf1fl/fl mice (Fig. 2-13e). In keeping with this, the frequency of pro-inflammatory 
IFN-γ, IL-17A and TNF-expressing Teff cells in cLP was remarkably increased in 
Cd4creUhrf1fl/fl mice (Fig. 2-13 f, g). Conversely, IL-10-expressing Treg cells were nearly 
absent in the colitic Cd4creUhrf1fl/fl mice (Fig. 2-13 f, g). This was also the case even in 
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younger mice before the development of frank colitis (Fig. 2-6j). These results suggest that 
activation of TH1 and TH17 responses due to compromised Treg function mediates the 
development of colitis in Cd4creUhrf1fl/fl mice. 
To examine the possibility that excessive activation of Teff cells due to the loss of 
Uhrf1 might be a cause of colitis development, we investigated the in vivo function of Teff cells 
independently of the effect of Treg dysfunction using a mixed BM chimera system. CD45.1+ WT 
and Uhrf1-deficient BM cells were co-transferred into irradiated Rag1-deficient recipients. We 
confirmed that these BM chimeras did not show any signs of inflammation in the colon (data not 
shown). Under these non-inflammatory conditions, the frequency of IFN-γ and 
IL-17A-expressing Teff cells in colonic lamina propria was comparable between Uhrf1-deficient 
and Uhrf1-sufficient cells (Fig. 2-7d). In addition, Uhrf1-deficiency did not influence the in 
vitro differentiation or function of the Teff cells (Fig. 2-16 a, b). Examination of methylated 
DNA by MeDP-seq analysis also confirmed that the methylation status of the 
proinflammatory cytokine genes as well as key transcription factor genes for TH1- or 
TH17-differentiation was normal in the absence of Uhrf1 (Fig. 2-16 c-f). These results 
excluded the possibility that deficiency of Uhrf1 influences the function of colonic Teff cells.  
We finally investigated whether the defect in Treg proliferation is responsible for the 
colitis development. To address this issue, young Cd4creUhrf1fl/fl mice received wild-type 
Treg (CD3+CD4+CD45.1+hCD2+) cells from congenic Foxp3hCD2 reporter mice. Adoptive 
transfer of the wild-type Treg cells prevented the development of colitis (Fig. 2-17a), 
concomitantly with suppression of the Teff response (Fig. 2-17b). Collectively, these data 
illustrate that the aberrant activation of Teff cells caused by Uhrf1 deficiency results from the 
breakdown of the colonic immunoregulatory system. From this model, we concluded that the 
proliferative response of Treg cells mediated by Uhrf1 is a prerequisite for their functional 
maturation in colonic mucosa. 
Taking all of these observations into account, we propose a model for establishment 
of gut immune homeostasis based on reciprocal interaction between Treg and Teff cells; 1) 
Colonizing bacteria should be initially recognized by antigen-presenting cells (APCs) such as 
DCs, 2) the antigen-loaded APCs evoke an early IL-2 response by stimulating Teff cells 
through antigen presentation, 3) the early IL-2 provides a cue for Treg cells to proliferate and 
simultaneously upregulates Uhrf1 expression, 4) Uhrf1 represses the cell cycle-dependent 
kinase inhibitor Cdkn1a via DNA methylation to safeguard the continuing proliferation of 
Treg cells, 5) the actively proliferating Treg cells become functionally mature and in turn 
prevent excessive immune responses to the colonizing microbiota. In conclusion, our study 
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provides a new mechanistic link between proliferation-dependent Treg maturation and 
containment of the inflammatory response to commensal microbiota (Fig. 2-18). 
 
4.  Figures and Tables 
4.1　Section I:  
 Commensal microbe-derived butyrate induces colonic regulatory T cells  
 Figures 1-1 to 1-26 and Table 1-1   
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Figure 1-1 |  Gut microbial metabolism is essential for the induction of colonic Treg cells.  
a, b, The caecum size of germ-free (GF) and CRB-associated mice. Representative caecum images are 
shown in a. Scale bars, 1 cm. c, d, The expression of neuropilin-1 and CD103 in Foxp3+ T cells in 
germ-free and CRB-associated mice fed a HFD or LFD for 4 weeks. Representative FACS plots gated 
on CD3+ CD4+ are shown in c. P value was determined by one-way analysis of variance (ANOVA) 
followed by Tukey’s post-hoc test. e, f, Caecal metabolomic profiling by NMR of germ-free and CRB 
mice fed a HFD or LFD. The results of PCA on the 1H-NMR data (e) and loading scatter plot (f) are 
shown. Proportions of the first (PC1) and second (PC2) principal components are 85.1% and 10.3%, 
respectively. The ellipse denotes the 95% significance limit of the model, as defined by Hotelling’s t-
test. g, h, Organic acids in caecal contents (g) and the proximal colonic tissue (h) were measured by 
gas chromatography–mass spectrometry. Ace, acetate; but, butyrate; pro, propionate. Error bars 
indicate s.e.m. (b, n = 5) or s.d. (d, n = 10; g, h, n = 7). All data are representative of two (e–h) or three 
(a–d) independent experiments.	
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Figure 1-2 | The number of total regulatory T cells in colonic lamina propria.	
Colonic lamina propria cells were prepared from GF and CRB mice fed with HFD and LFD. 
CD3ε+CD4+ T cells were further analyzed for expression of Foxp3, Neuropilin1 and CD103. 
Data are representative of three independent experiments. The Error bars indicate s.d. (n = 10). 
P values were determined by the one-way ANOVA test followed by Tukey’s test. 	
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Figure 1-3 | Helios expression in Foxp3+ cells in the colonic lamina propria.	
Colonic lamina propria cells were prepared from GF and CRB mice fed with HFD and 
LFD. CD3ε+CD4+ T cells were further analyzed for expression of Foxp3 and Helios. 
Data are representative of three independent experiments. The Error bars indicate s.d. 
(n = 10). P values were determined by the one-way ANOVA test followed by Tukey’s 
test. 	
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Figure 1-4 | Flow cytometric analysis of lymphocytes in spleen and mesenteric 
lymph node (MLN).	
MLN (a) and spleen (b) lymphocytes were prepared from GF and CRB mice fed with 
HFD and LFD. CD3ε+CD4+ T cells were further analyzed for expression of the 
indicated markers. The Error bars indicate s.d. (n = 5). Data are representative of three 
independent experiments. 	
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Figure 1-5 | 16S rRNA sequence-based analysis of the cecal microbiota of CRB-associated 
mice fed with LFD or HFD. 	
a-d, 16S rRNA gene was PCR amplified and sequenced on the 454 platform (n = 2). Phylum (a), 
class (b), order (c) and family; genus in Clostridiales (d) are shown.	
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Figure 1-6 | Phylogenetic distribution of operational taxonomic units (OTUs) obtained from 16S rRNA 
sequences in order Clostriales colonized in CRB mice.  
12,000 filter-passed reads of 16S rRNA sequences in CRB mice were used for OTUs and a phylogenetic tree was 
constructed based on the CRB-derived 114 OTUs which were categorized into Clostridiales by RDP-classifier 
(v2.5) and 69 reference 16S rRNA sequences of Clostridiales obtained from the GenBank database. The 16S rRNA 
sequence of Escherichia coli was used as the outgroup. The phylogenetic tree was constructed based on the 
neighbor-joining method, with 100 bootstrap iterations (bootstrap values > 70 are shown on each branch). The scale 
bar indicates an estimated 0.1 change per nucleotide position. Colors configuring a doughnut shape represent the 
branches consisting of the distinct clusters of Clostridiales. The reference 16S rRNA sequences from spore forming, 
non-spore forming, and unknown spore forming capacity bacteria are shown in blue, purple and black, respectively. 
The outside red and green bars indicate the relative number of sequence reads in each OTU from CRB-HFD and 
CRB-LFD, respectively. Most of OTUs both in CRB-HFD and CRB-LFD were clustered into Clostridium clusters 
IV and XIVa. 
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Figure 1-7 | The number of total commensal microbes and Clostridiales in GF, and 
CRB mice fed with HFD and LFD.	
a, b, Total number of commensal microbes (a) and Clostridiales (b) were detected by 
qPCR with 16S rRNA gene universal primers and Clostridiales-specific primers. The 
results were calculated as the quantity relative to the copy number detected in the feces of 
conventionalized mice (CV). Error bars indicate s.e.m. (n = 5). P values were determined 
using the Kruskal-Wallis test followed by the Scheffé test. n.s., not significantly different. 
n.d., not detected. 	
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Figure 1-8 | Orthogonal partial least squares discriminate analysis (OPLS-DA) on the 
cecal metabolome data of CRB-LFD and CRB-HFD mice.  
a,  Cross-validated score plots from OPLS-DA of 1H-NMR data of CRB-LFD and CRB-HFD 
murine cecum (n = 7). The model resulted in one predictive and one orthogonal (1+1) 
components with the cross-validated predictive ability Q2(Y) = 0.93 and the total explained 
variance R2(X) = 0.79. The ellipse denotes the 95% significance limit of the model, as defined 
by Hotelling’s t-test. b, S-plot for predictive component from OPLS-DA of 1H-NMR data of 
CRB-LFD and CRB-HFD murine cecum. The S-plot visualizes the variable influence in a 
model and corresponds to combining the contribution or magnitude (covariance) with the 
effect and reliability (correlation) for the model variables with respect to model component 
scores. The highlighted signals (|covariance| > 0.16 ) in the S-plot have high contribution and 
reliability for class separation between CRB-LFD and CRB-HFD mice.  
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Figure 1-9 | Butyrate induces the differentiation of Treg cells in the colonic lamina propria.  
a, b, Naive CD4+ T cells were stimulated with immobilized anti-CD3 and soluble anti-CD28 
monoclonal antibodies in the absence (untreated; UT) or presence of acetate, propionate or 
butyrate. Representative FACS plots are shown in a. c, Amount of caecal SCFA in the mice fed 
with control HAMS diet or diets containing HAMSA, HAMSP or HAMSB (SA, SP or SB, 
respectively). d, e, FACS profile of colonic lamina propria cells. The representative FACS plots 
gated on CD3e+ CD4+ cells are shown in d. e, The frequency of neuropilin-1− and neuropilin-1+ 
Foxp3+cells among CD4+ T cells. f, g, The percentage and total number of OVA-induced Foxp3+ 
cells in mice fed with HAMS (control; ctrl) or HAMSB (SB). Representative FACS plots gated on 
CD3e+ CD4+ CD45.2+are shown in f. CD45.2+ Va2+ CD4+ T cells were sorted and adoptively 
transferred into CD45.1+ C57BL/6 recipients, followed by administration of drinking water 
containing 1% ovalbumin (OVA) for 9 days before analysis. h, Percentage of IL-10+ cells among 
CD25+ FR4+ colonic Treg cells in SPF C57BL/6 mice fed with HAMS or HAMSB. Error bars 
indicate s.d. (b, n = 3; c, n = 4; e, n = 5; g, n = 4 for control and n = 5 for SB; h, n = 5). P values 
determined by non-parametrical Mann–Whitney U test (g, h) or one-way ANOVA followed by 
Tukey’s post-hoc test (b, e). All data are representative of at least two independent experiments. 
NS, not significant.	
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Figure 1-10 | Leucine, Isoleucine and GABA have no effect on the induction of Foxp3+ cells	
a, b, c, Naïve CD4+ T cells were cultured under Treg-inducing conditions in vitro. The cells 
were cultured in RPMI 1640 medium, which contains 0.38 mM each of L-leucine and L-
isoleucine, that was supplemented with L-leucine (0, 0,12 and 0.62 mM) (a), L-isoleucine (0, 
0,12 and 0.62 mM) (b) or GABA (0, 0,001, 0.01 and 0.1 mM) (c). Cells were further analyzed 
for expression of Foxp3. The Error bars indicate s.d. (n = 3). 	
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Figure 1-11 | The number of total Foxp3+ cells in colonic lamina propria of C57BL/6 mice 
fed with HAMS or HAMSB.  
Colonic lamina propria cells were prepared from C57BL/6 mice fed with HAMS (Cont) or 
HAMSB (SB). CD3ε+CD4+ T cells were further analyzed for expression of Foxp3. Data are 
representative of three independent experiments. The Error bars indicate s.d. (n = 10). P values 
were determined by the non-parametrical Mann-Whitney U test 	
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Figure 1-12 | Butyrate has no effect on proliferation of Treg cells in colonic 
lamina propria.  
a, Mice fed with HAMS (Control) or HAMSB (SB) were treated with EdU, a 
nucleoside analog incorporated into DNA during synthesis phase of cell cycle, for 2 
days before the analysis. Colonic lamina propria cells were prepared from those mice 
and CD3ε+CD4+ T cells were further analyzed for expression of Foxp3 and EdU. The 
Error bars indicate s.d. (n = 5).	
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Figure 1-13 | Butyrate has no effect on cell survival under Treg-inducing conditions in 
vitro. 	
The number of total cells under Treg-inducing condition cultures in the absence or 
presence of butyrate. Cells were cultured as described in Fig.3a. The viability was 
evaluated by Trypan blue dye exclusion test. The Error bars indicate s.d. (n = 5).	
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Figure 1-14 | Intestinal butyrate induces the accumulation of Neuropilin- and Helios- 
subsets of Treg cells in mice colonized with Bacteroides thetaiotaomicron.  
GF mice were colonized with B. thetaiotaomicron. B. thetaiotaomicron-associated mice were 
fed with HAMS (Cont) or HAMSB (SB) for 4 weeks. a, Colonic lamina propria cells were 
prepared and CD3ε+CD4+-gated cells were further analyzed for expression of Foxp3, Neuropilin 
and Helios. P values were determined by the non-parametrical Mann-Whitney U test. b, Cecal 
and fecal amount of short-chain fatty acids from B. thetaiotaomicron-associated mice fed with 
HAMS or HAMSB. Ace, acetate; Pro, propionate; But, butyrate. The Error bars indicate s.d. (n 
= 5).	
 	
a	
b	
0	  	  
2	  	  
4	  	  
6	  	  
8	  	  
10	  	  
12	  	  
14	  	  
16	  	  
µm
ol
/g
	
0	  	  
5	  	  
10	  	  
15	  	  
20	  	  
25	  	  
30	  	  
35	  	  
µm
ol
/g
	
(x104)	
(x104)	
Cont	 SB	
Gated	  on	  CD3ε+	  CD4+	
Cont	 SB	
Cont	  
SB	  
Cont	  
SB	  
Ace	 Pro	 But	 Ace	 Pro	 But	
Cont	 SB	
4.1 Figures, Section I	
36	
CD4	
Fo
xp
3	
Cont	 SB	
0	  
5	  
10	  
15	  
20	  
25	  
30	  
0	  
5	  
10	  
15	  
20	  
(x104)	
To
ta
l	  n
um
be
r	  o
f	  F
ox
p3
+	  
ce
lls
	
Gated	  on	  CD3ε+	  CD4+	
[%
]	  o
f	  F
ox
p3
+	
n.s.	
n.s.	
Figure 1-15 | Butyrate has no effect on Foxp3+ induction in colonic lamina propria of GF 
mice fed with HAMS or HAMSB.  
a, Colonic lamina propria cells were prepared from GF mice fed with HAMS (Cont) or 
HAMSB (SB). CD3ε+CD4+ T cells were further analyzed for expression of Foxp3. b, Amount 
of cecal short-chain fatty acids from GF mice fed with HAMS or HAMSB. Ace, acetate; Pro, 
propionate; But, butyrate. Data are representative of three independent experiments. n.s., not 
statistically significant. The Error bars indicate s.d. (n = 5).	
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Figure 1-16 | Intestinal butyrate has no effect on the accumulation of T-bet+, GATA3+ 
and RORγt+ T cells.  
Colonic lamina propria cells were prepared from SPF C57BL/6 mice fed with HAMS 
(Control or Cont) or HAMSB (SB). CD3ε+CD4+ T cells were further analyzed for 
expressions of T-bet, GATA3, and RORγt, the lineage-specific transcription factors of TH1, 
TH2, and TH17, respectively. The Error bars indicate s.d. (n = 10). P-values were calculated 
by Mann-Whitney U test. Data are representative of three independent experiments.	
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Figure 1-17 | Butyrate increases the frequency of Foxp3+ T cells under TH1 and TH17 polarizing 
conditions.  
a, b, Naïve CD4+ T cells were stimulated with immobilized anti-CD3 and soluble anti-CD28 antibodies. Cells 
were cultured in the presence or absence of butyrate and either with rIL-12 (10 ng/mL) plus anti-IL-4 (10 mg/
mL) for TH1 polarization, with rIL-4 (10 ng/mL) plus anti-IFNγ (10 mg/mL) for TH2 polarization or with rIL-6 
(10 ng/mL), rhTGFβ (0.2 ng/mL), rIL-1β (10 ng/mL), anti-IFNγ  plus anti-IL-4 for TH17 polarization.  rIL-2  
(10 ng/mL) was added to culture medium 2 days later. Cells were further analyzed for expression of Foxp3, T-
bet, Gata3 and RORγt on day 4. Representative FACS plots gated on CD3ε+CD4+ are shown in c. The Error bars 
indicate s.d. (n = 3). P-values were calculated by Mann-Whitney U test. Data are representative of three 
independent experiments.	
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Figure 1-18 | Induction of colonic Treg cells by intestinal butyrate in SPF Myd88-/-
Ticam1-/- mice.	
a-b, SPF Myd88-/-Ticam1-/-  mice were fed with HAMS (Cont) or HAMSB (SB). 
Representative FACS plots gated on CD3ε+CD4+ are shown in a. The frequency and total 
number of Helios- Foxp3+ cells among colonic CD4+ T cells are shown in b. Data are 
representative of two independent experiments. The Error bars indicate s.d. (n = 4). P-
values were calculated by Mann-Whitney U test.	
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b	
Fig. 1-19 | Genome-wide histone H3 acetylation status after butyrate exposure. 
Naïve CD4+ T cells were cultured under Treg-inducing conditions in the presence or 
absence (control) of butyrate for 1 day. a, Total and acetylated histone H3 (AcH3) were 
measured by Western blot analysis of total cell lysates. b, ChIP-Seq analysis was 
performed using anti-AcH3 antibody. The average values of AcH3 status around the 
transcription start site (TSS) over total genes are shown. 	
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Figure 1-20 | Chromatin modification at the Foxp3 locus by butyrate.  
a, Time-course analysis on the differentiation of naive T cells into Foxp3+ Treg cells. Naive CD4+ T cells 
were cultured under Treg-cell-inducing condition in the absence (−) or presence (+) of butyrate. b–d, 
Acetylated histone H3 (AcH3) status of transcriptional regulator genes at day 1 after butyrate exposure 
was determined by ChIP-seq analysis. Distribution of acetylation changes in the gene loci encoding 
transcription factors (TF) were fitted using multiple Gaussian distributions with the expectation–
maximization algorithm (b). Using this analysis, we identified two groups representing upper (highly 
acetylated) and lower (moderately or not acetylated) transcriptional regulator genes after butyrate 
treatment. The threshold was set so that the false discovery ratio (FDR) in the upper group was 0.01, 
where 99% of transcriptional regulators with a high acetylation changes belonged to the upper group (b, 
pink area). Correlation of gene expression changes and the acetylated H3 status in transcriptional 
regulators is shown in c. Gene expression was analysed by microarray at day 2. The normalized number 
of sequence tags of DNA at the Foxp3 promoter and gene body is shown in d. ChrX, chromosome X. e, 
ChIP quantitative PCR (qPCR) analysis of the Foxp3 promoter and enhancer regions was performed in 
CD4+ T cells cultured in the presence or absence of butyrate, using anti-AcH3 antibody or rabbit IgG as a 
negative control. Error bars indicate s.d (a, e, n = 3). 	
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Figure 1-21 | Histone acetylation status of Tbx21, Gata3 and Rorc.	
Naïve CD4+ T cells were cultured under Treg-inducing conditions in the presence or 
absence (control) of butyrate for 1 day. Histone acetylation in the genes encoding master 
molecules for effector T cells was analyzed by ChIP-sequencing using anti-acetylated 
histone H3.  	
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Figure 1-22 | Histone acetylation status of Stat5, Smad3, Nfatc2 and Rel.	
Naïve CD4+ T cells were cultured under Treg-inducing conditions in the presence or absence 
(control) of butyrate for 1 day. Histone acetylation in the genes encoding transcriptional regulators 
controlling Foxp3 expression was analyzed by ChIP-sequencing using anti-acetylated histone H3.  	
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Figure 1-23 | Expression of STAT5, SMAD3, NFAT1, and c-Rel. 
Naïve CD4+ T cells were cultured under Treg-inducing conditions in the absence or 
presence of butyrate. Total cell lysates were subjected to western blotting analysis with 
antibodies described in Methods.  H3 and AcH3 indicate histone H3 and acetylated histone 
H3, respectively. Data are representative of three independent experiments. 	
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Figure 1-24 | Butyrate ameliorates T-cell-dependent experimental colitis.  
a–f, Experimental colitis was induced by adoptive transfer of CD4+ CD45RBhi T cells in Rag1−/− mice 
fed with HAMS or HAMSB. a, Body weight change was monitored. b–f, The number of colonic 
lamina propria (LP)-infiltrating mononuclear cells (b) and histological score (c), representative 
colonic specimens stained with haematoxylin and eosin (HE) and Alcian blue (AB) (d), representative 
immunofluorescent staining images for CD4, CD11b, CD11c and nuclei (blue) (e) and the frequency 
of Foxp3+ cells in the colonic mucosa (f) were analysed at 6 weeks after the cell transfer. g–k, CD4+ 
CD45RBhi T cells from Foxp3hCD2 reporter mice were transferred into Rag1−/− recipients, which were 
injected intravenously with anti-human CD2 monoclonal antibody twice at 4 and 5 weeks after the 
cell transfer. Depletion of Foxp3+ cells in the colonic lamina propria was confirmed by FACS analysis 
(g). The mice were analysed for colitis development at 6 weeks after transfer (h–k). Turquoise blue 
represents goblet cells (d, h, bottom). Error bars indicate s.d. (a, b, c, f, n = 5; i–k, n = 4). P values 
were determined by two-way repeated measures ANOVA followed by Tukey’s test (a) and non-
parametrical Mann–Whitney U test (b, c, i–k). **P < 0.01 (a). Scale bars, 200 mm (d, e, h). All data 
are representative of two independent experiments.	
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Figure 1-25 | Intestinal butyrate, but not acetate or propionate, ameliorates T-cell-
dependent experimental colitis.	
a-f, Experimental colitis was induced by adoptive transfer of CD4+CD45RBhi T cells in 
Rag1-/- mice fed with HAMS (Control), HAMSA (SA), HAMSP (SP)  or HAMSB (SB). 
Fecal amount of SCFAs (a), body weight change (b), and representative colonic specimens 
stained with hematoxylin-eosin (HE) and Alcian blue (AB) (c) are shown. The Error bars 
indicate s.d. (n = 5). Scale bars: 200 µm (c). All data are representative of two independent 
experiments. 	
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Figure 1-26 | A schematic diagram of epigenetic modifications by commensal 
microbial fermentation product. 	
Clostridiales abundantly produce butyrate, which promotes histone H3 lysine acetylation 
in Foxp3 gene locus of CD4+ T cells, and eventually facilitates induction of Treg cells. 
APC: antigen-presenting cells.	
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Table 1-1. Key observed cecal metabolites most influential in discriminating between CRB-
LFD and CRB-HFD mice in the S-plot shown in Figure 1-8. 
　	 　	 　	 　	 　	 　	 　	 　	
1H Chemical 
shift (ppm)	
Metabolite	 Covariance	
Modeled 
correlation	
Normalized signal 
intensitiy (a.u.)	
Fold 
change 
(HFD/
LFD)	
P value	
CRB-LFD	 CRB-HFD	
2.13 	
Butyrate/
Propionate	
0.199 	 0.973 	 11.3±0.2	 18.4±0.6	 1.62 	   <0.001	
0.96 	 L-Leucine	 0.196 	 0.926 	 21.8±0.7	 28.8±0.8	 1.32 	   <0.001	
1.00 	 L-Isoleucine	 0.195 	 0.962 	 9.6±0.4	 16.3±0.7	 1.71 	   <0.001	
3.01 	 GABA	 0.176 	 0.975 	 8.1±0.2	 13.7±0.3	 1.70 	   <0.001	
1.89 	 Acetate	 0.174 	 0.722 	 19.2±1.3	 26.8±1.5	 1.39 	 0.003	
3.74 	 L-Leucine	 0.174 	 0.908 	 17.4±0.4	 23.3±0.7	 1.34 	   <0.001	
1.53 	 Butyrate	 0.166 	 0.924 	 11.3±0.3	 16.7±0.5	 1.47 	   <0.001	
1.73 	 L-Leucine	 0.162 	 0.979 	 0.8±0.3	 15.5±0.3	 1.44 	   <0.001	
0.84 	 Unidentified	 -0.211 	 -0.991 	 14.5±0.3	 6.7±0.5	 0.45 	   <0.001	
1.29 	 Lactate	 -0.258 	 -0.962 	 20.4±1.2	 8.3±0.1	 0.40 	   <0.001	
The normalized signal intensity of each metabolie is shown as the mean
±SE (n = 7)	
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4.2　Section II:  
 The epigenetic regulator Uhrf1 facilitates functional expansion of colonic regulatory T cells  
 Figures 2-1 to 2-18  
Epigenetic modifications and immune regulation by gut microbiota	
Yuuki OBATA	
50	
C
el
ls
 (%
)
a
b
50
40
30
20
10
0
0 1 3 5 7
Foxp3+ Ki67+
Foxp3+
c
54.345.7 30.968.98.3392.3 8.8990.9
4.8695.1 11.888.2 44569.1490.9
C
el
ls
EdU
exGF
Foxp3+
GF
Foxp3–
Foxp3+Nrp1– Foxp3+Nrp1+
*
Fo
xp
3–
 ce
lls
 (%
)
N
rp
1–
 c
el
ls
 (%
)
0
20
40
60
0
20
40
60
80
exGFGF
exGFGFexGFGF
**
0
20
40
60
3.7596.2 13.286.8
cLP
Spleen
9.3390.7 16.683.3
C
el
ls
EdU
exGFGFexGFGF
IL-2+
cLP
0
20
40
60
Ed
U
+ 
ce
lls
 (%
)
d
IgG
α4β7
NS
GF
exGF
**
Fo
xp
3+
 ce
lls
 (%
)
0
20
40
60
0
20
40
60
N
rp
1+
 ce
lls
 (%
)
0
20
40
60
80
**
**
**
Time (d)
Fo
xp
3–
 ce
lls
 (%
)
Fo
xp
3+
 ce
lls
 (%
)
0 102 103 104 105 0 102 103 104 105 0 102 103 104 105 0 102 103 104 105
0 102 103 104 105 0 102 103 104 105 0 102 103 104 105 0 102 103 104 105
0 102 103 104 105 0 102 103 104 105 0 102 103 104 105 0 102 103 104 105
6
4
2
0
6
4
2
0
6
4
2
0
12
9
6
3
0
60
40
20
0
60
40
20
0
80
800
600
400
200
0
800
600
400
200
0
250
200
150
100
0
50
50
40
30
0
20
10
60
40
20
0
12
9
6
3
0
Figure 2-1 | Bacterial colonization induces vigorous proliferation of Treg cells in the colonic 
mucosa	
a-d, GF IQI mice were inoculated orally with fecal suspension from SPF C57BL/6 mice. IL-2+ (blue 
line), total Foxp3+ (black line) or Ki67+Foxp3+ (red line) CD4+ T cells were enumerated in the cLP at 
the indicated time points by flow cytometry and were described as pooled data (n = 2 or 3 at each time 
point) (a). The mice were treated with EdU for 2 days before the analysis. EdU+ proliferating cells 
were detected in cLP and spleen of GF and exGF mice at day 7 after bacterial colonization (b). 
Foxp3+CD4+ T cells were subdivided into two populations based on the expression of Neuropilin1 
(Nrp1) to analyze proliferative status of these subpopulations (c). exGF mice received neutralizing 
antibodies against α4β7 integrin subunits prior to the administration of EdU in exGF mice. EdU+ 
proliferating cells in Foxp3+CD4+ T cells were detected in cLP of exGF mice at day 5 after bacterial 
colonization (d) Data are representative of at least two or three independent experiments. Error bars: 
s.d. (n = 5, b-c; n = 3, d), **P < 0.01, *P < 0.05, NS.: not significantly different, as calculated by 
Student’s t test (b-d). 	
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Figure 2-2 | Time course analysis of splenic and colonic Treg cells in exGF mice and young age mice. a, 
GF IQI mice were inoculated with a fecal suspension from SPF C57BL/6 mice. Splenic CD4+ T cells were 
analyzed for Foxp3 and Ki67 expression by flow cytometory after bacterial colonization. Data are 
representative of at least three independent experiments with similar results. b, CD4+ T cells in cLP of SPF 
C57BL/6 mice at the indicated ages were analyzed for Foxp3, IL-2 and Ki67 expression by flow cytometory. c, 
CD3ε+CD4+CD25+FR4+ Treg cells from the cLP of 2 (infant) and 11 (adult) week-old mice (n = 11 or 3 for 2 or 11 
weeks old, respectively) were pooled in each group before analyzing the expression of Uhrf1 by Q-PCR. d, Splenic 
CD4+ T cells from SPF C57BL/6 mice at the indicated ages were analyzed for Foxp3 and Ki67 expression by 
flow cytometory. Data are representative of two independent experiments with similar results. e, Splenic Treg 
cells (CD3+CD4+CD25+FR4+) from GF or exGF mice at day 7 (n = 3 per group) were pooled in each group 
before analyzing Uhrf1 expression levels by Q-PCR.	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Figure 2-3 | IL-2 is responsible for the vigorous proliferation of colonic Treg cells after 
inoculation of commensal bacteria	
a-b, IQI mice were injected intravenously with IL-2-neutralizing antibody (α-IL-2) or control 
IgG 3 days after bacterial colonization. Two days later, CD4+ T cells in cLP were analyzed for 
Foxp3 expression (a) and proliferation (b) in CD4+ T cells. Representative flow cytometry plots 
are shown. Data are representative of at least three independent experiments. Error bars: s.d. (n = 
3), **P < 0.01, *P < 0.05, as calculated by one-way ANOVA test followed by Tukey’s test (a) or 
Student’s t test (b). NS: not significantly different. 	
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Figure 2-4 | Colonization with commensal bacteria induces Uhrf1 expression in colonic Treg cells in IL-2-
dependent manner.	
a, CD3ε+CD4+CD25-FR4- cells (Tconv) and CD3ε+CD4+CD25+FR4+ (Treg) cells were isolated from the cLP to 
analyze gene expression profiles. b, In vitro-cultured Treg cells were stimulated with IL-2 in the presence of TGF-β for 
2 days. c, The genes common to Clusters I and II were further subjected to gene ontology (GO) enrichment analysis. d, 
f, GF IQI mice were inoculated orally with feces from SPF C57BL/6 mice and expression of Uhrf1 in the indicated 
cell types from the cLP were analyzed by Q-PCR at day 7 (d). IQI mice were injected intravenously with anti-IL-2-
neutralizing antibody or control IgG two days before the analysis at day 5 (f). e, CD3ε+CD4+hCD2-CD44loCD62Lhi 
(Tnaive), CD3ε+CD4+hCD2-CD44hiCD62Llo (Teff) and CD3ε+CD4+hCD2+ (Treg) populations from SPF Foxp3hCD2 
mice were analyzed for Uhrf1 expression. g-i, GF IQI mice were inoculated with the 17-strain mixture of Clostridia. 
Expression of Il2 in the Tconv at day 3 (g) and Uhrf1 in Treg at day 6 (h) after the inoculation were analyzed by Q-
PCR. Frequency of Foxp3+Ki67+ cells in cLP at day 6 were analyzed by flow cytometry (i). j-k, Splenic CD4+CD25+ 
T cells were cultured for 3 days with anti-CD3-CD28 mAbs-coated beads in the presence of IL-2 and TGF-β, allowed 
to rest for 6 h and then stimulated with or without IL-2 for 1.5 (k) or 24 h (j). Uhrf1 expression was analyzed by Q-
PCR (j). The binding of STAT5 to the Uhrf1 promoter region was analyzed by ChIP-Q-PCR. Values normalized to 
Actb (encoding b-actin, d-f) or Rpl13a (g-j) are shown. Error bars: s.e.m (n = 3, d) or s.d. (n = 3, e, f, g, h, i, j, k), **P 
< 0.01, *P < 0.05, as calculated by one-way ANOVA test followed by Tukey’s test (e, d, k), Student’s t test (h, j) or 
Mann-Whitney U test (f, g, i).	
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Figure 2-5 | Composition of B, T lymphocytes and Treg cells in lymphoid tissues and cLP of 
Cd4creUhrf1+/+ and Cd4creUhrf1fl/fl mice.	 
a, Schematic representation of the genomic structure of wild-type murine Uhrf1 gene, the 
resultant mutant allele generated by homologous recombination and carrying the neomycin 
resistance gene (Neo), and the locus after removal of the Neo gene. Exons are indicated by 
boxes. b-d, Lymphocytes in cLP, mesenteric lymph node (MLN), spleen and thymus of 
Cd4CreUhrf1+/+ (+/+) and Cd4CreUhrf1fl/fl (fl/fl) mice at 5 weeks of age were characterized by 
flow cytometry. The frequency of Treg cells were analyzed by flow cytometory (d). Data are 
representative of at least three independent experiments with similar results. 	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Figure 2-6 | Deletion of Uhrf1 impairs proliferation and function of colonic Treg cells. 	
a, Nrp1+ and Nrp1– Treg cells in cLP of Cd4CreUhrf1+/+ (+/+) and Cd4CreUhrf1fl/fl (fl/fl) mice at 5 weeks of age were 
characterized by flow cytometry. b-d, Splenic naive CD4+ T cells were cultured with anti-CD3-CD28 mAbs-coated 
beads, TGF-b and IL-2 for 3 days to induce differentiation into Foxp3+ cells (inducible Treg cells), and then expanded 
without TCR stimulation for an additional 4 days. The effect of Uhrf1-deficiency on Treg differentiation was examined 
at day 3 (b). Cell numbers were determined on the indicated days of culture (c). The cells at day 5 were treated with 
EdU for 2 h to perform cell cycle assays (d). e-f, Frequency of Ki67+ cells in cLP were analyzed by flow cytometry. g, 
+/+ and fl/fl mice were reared under GF conditions. CD4+ T cells in cLP of 8-week-old mice were analyzed for Foxp3 
and Nrp1 expressions. h, The GF mice were inoculated with chloroform-resistant bacteria (CRB). Four weeks later, 
Foxp3 expression by CD4+ T cells in the cLP was analyzed. i, +/+ and F/F mice received IL-2-anti-IL-2 mAb 
complexes. Splenic CD4+ T cells were analyzed for Foxp3 and Ki67 expressions by flow cytometory. j, IL-10 and 
CTLA-4 expression by Foxp3+ cells in the cLP under SPF conditions was analyzed. Representative flow cytometry 
plots gated on CD3ε+CD4+ cells (a, b, e, g, h, i, j) and CD3ε+CD4+Foxp3+ (f) are shown. Data are representative of 
three independent experiments. Error bars: s.d. (n = 4-9). **P < 0.01, *P < 0.05, as calculated by one-way ANOVA test 
followed by Tukey’s test (i) or Mann-Whitney U test (b) or Student’s t test (a, e, f, h, j). NS: not significantly different. 	
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Figure 2-7 | BM chimera experiment for the analysis of Treg and Teff cells	 
a, In preliminary experiments, after adoptive transfer of an equivalent number of CD45.1+ WT and 
Uhrf1-deficient BM cells into irradiated Rag1-deficient recipients, the WT CD4+ T cells became 
dominant (data not shown), indicating that Uhrf1 confers competitive fitness on T cells during T cell 
development in the thymus. We therefore increased the ratio of Uhrf1-deficient BM cells to gain 
comparable numbers of peripheral CD45.2+ Uhrf1-deficient and CD45.1+ CD4+ WT T cells as 
described. b, The ratio of CD45.1+ and CD45.2+ cells in the cLP  of the mixed bone marrow 
chimeric mice were shown. c-d, CD4+ T cells in cLP from mixed BM chimera mice were analyzed 
for Foxp3 (c) or cytokine expression (d) at 6 weeks after the BM transfer. Representative FACS 
plots are shown. Data are representative of two independent experiments with similar results. Error 
bars: s.e.m. (n = 8). **P < 0.01, as calculated by Mann-Whitney U test. NS: not significant. 	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Figure 2-8 | Deficiency of Uhrf1 does not affect the colonic Treg differentiation 
a-b, In vivo generation of Foxp3+ T cells after adoptive transfer of naive CD4+ T cells from 
Cd4creUhrf1+/+ and Cd4creUhrf1fl/fl mice. A schematic diagram of in vivo differentiation assay 
of Foxp3+ T cells (a). CD4+CD44loCD62hi naive T cells from Cd4creUhrf1+/+ and 
Cd4creUhrf1fl/fl mice were intravenously injected into congenic Foxp3hCD2 reporter mice. The 
cLP cells in the recipient mice were analyzed for Foxp3 expression at day 14 after transfer 
(b). Representative FACS plots are shown. Data are representative of two independent 
experiments with similar results. 	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Figure 2-9 | Ablation of Uhrf1 impairs expression of functional molecules by Treg cells 
a, Expression levels of functional molecules by proliferative and non-proliferative Treg cells in cLP. 
Ki67+ and Ki67- Treg cells from cLP of 16-week-old C57BL/6 Foxp3hCD2 reporter mice were 
analyzed for CTLA-4, ICOS and GITR expression by flow cytometry. Mean fluorescent intensity 
(MFI) in each population is shown in the histograms. b, Foxp3+ Treg cells in cLP of 
Cd4CreUhrf1+/+ (+/+) and Cd4CreUhrf1fl/fl (fl/fl) mice were analyzed for PD-1, ICOS and GITR 
expression by flow cytometry. Histograms gated on CD3ε+CD4+hCD2+ cells are shown. Data are 
representative of two independent experiments with similar results. 	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Figure 2-10 | Treg immunosuppressive function is attenuated in Uhrf1-deficient Tregs both in vitro 
and in vivo.	 
a, CFSE-labeled responder cells were co-cultured with Treg cells from MLN of Cd4CreUhrf1+/+ (+/+) or 
Cd4CreUhrf1fl/fl (fl/fl) mice at 1:1 ratios in the presence of APCs and anti-CD3 antibody. The numbers in 
the histograms indicate the percentage of cells that had undergone one or more divisions. Data are 
representative of three independent experiments with similar results. Error bars: s.d. (n = 3). **P < 0.01, as 
calculated by the one-way ANOVA followed by Tukey’s test. b-c, Experimental colitis was induced in 
Rag1-/- mice by adoptive transfer of CD4+CD25-CD45RBhi T cells from CD45.1+ C57BL/6 mice. 
CD4+CD25+ T cells from CD45.2+ Cd4creUhrf1+/+ (+/+) or Cd4creUhrf1fl/fl (fl/fl) mice were co-transferred 
in the group shown in the middle or right panels, respectively. Histological examination by hematoxylin-
eosin (upper) and Alcian blue staining (lower) are shown (b). Scale bars: 200 µm. CD4+ T cells in cLP 
were analyzed for CD45.2 and Foxp3 expression at 6 weeks after the transfer (c). Representative FACS 
plots are shown. Data are representative of two independent experiments with similar results. 	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Figure 2-11 | Identification of the molecule responsible for cell cycle arrest in Uhrf1-deficient 
Treg cells	 
a-c, Global gene expression profiles of colonic Tconv and Treg from Cd4CreUhrf1+/+ (+/+) or 
Cd4CreUhrf1fl/fl (fl/fl) mice. Heat map shows the upregulated genes in colonic Treg cells from 
Cd4CreUhrf1fl/fl (fl/fl) mice (a). Functional category analysis of the profiled 251 genes classified a 
group of genes termed ‘cellular growth and proliferation’ at the top of the list (b). Subsequent 
computational gene network analysis identified a molecular network composed of 16 genes (c). 	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Molecular and Cellular Functionsa p-value Molecules 
Cellular Growth and Proliferation  3.32E-11 - 
5.90E-03 90 
Antigen presentation  3.67E-11 - 
6.45E-03 37 
Cellular Function and Maintenance  3.67E-11 - 
6.44E-03 60 
                a Top3 functions were shown.  
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Figure 2-12 | Cdkn1a is upregulated in Uhrf1-deficient Treg cells due to the hypomethylation of 
the promoter region	
a, Genome-wide MeDP-seq analysis was performed using DNA samples from the indicated T cell types. 
Average of DNA methylation status around genic regions are shown. b, Comparable transcriptome 
analysis was performed in Uhrf1-sufficent (+/+) and Uhrf1-deficient (fl/fl) Treg cells, and then 
compared to MeDP-seq analysis data to identify potential target molecules for Uhrf1. c, Expression of 
Uhrf1 and Cdkn1a were measured in in vitro cultured Treg cells by Q-PCR (c) and immunoblotting (d). 
The asterisk indicates a non-specific signal. e, DNA methylation status was analyzed by MeDP-seq in ex 
vivo CD3e+CD4+hCD2+ cells. The arrowhead represents the distal promoter region of Cdkn1a. The exon 
structure of the Cdkn1a gene is depicted below. The coding sequences are shown in orange, the UTR in 
tan and the direction of transcription by arrows. f-g, DNA methylation of CpG islands on the distal 
promoter region of Cdkn1a was analyzed by bisulfite-seq in ex vivo Treg and Tconv cells (f) and in 
vitro-cultured Treg cells (g). h, Uhrf1-deficient naive CD4+ T cells were differentiated into Foxp3+ cells 
before treatment with Hilyte 488-labeled siRNA specific for Cdkn1a or a non-targeting control siRNA. 
Treatment with Cdkn1a-specifc siRNA reduced Cdkn1a expression by 45%. After 24 h, a cell cycle 
assay was performed. Data are representative of two (a, b, e-g) or three (c, d, h) independent 
experiments. **P < 0.01, as calculated by Student’s t test (c) or *P = 5.94×10-5, **P = 4.34×10-13, ***P = 
7.18×10-14, ****P = 3.12×10-21 as calculated by hypergeometric distribution (f, g). NS: not significantly 
different.	
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Figure 2-13 | Uhrf1-deficient mice spontaneously develop colitis characterized by activation of TH1 
and TH17 responses. 	
a-g, Cd4creUhrf1fl/fl (fl/fl) and control littermate (+/+) mice were maintained under SPF conditions until 
12 weeks of age. Representative colonic sections stained with hematoxylin-eosin (H&E) and Alcian blue 
(a), colon weight measurement (b, n = 8), histological score (c, n = 8), and representative 
immunofluorescent staining images of the colonic tissues for CD4, CD11b, CD11c together with nuclei 
counterstaining (blue) (d) are shown. Expression of the indicated cytokine mRNAs in the colonic tissue 
were analyzed by Q-PCR (e, n = 11). The data were normalized to expression of Actb. Cytokine 
expression profiles in cLP-infiltrating CD4+ T cells were analyzed by flow cytometry (f-g). Data are 
representative of three independent experiments. Error bars: s.d. *P < 0.05, **P < 0.01, as calculated by 
Mann-Whitney U test (b, c, e) or Student’s t test (g). Scale bars: 200 µm. 	
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Figure 2-14 | Cd4creUhrf1fl/fl mice under GF conditions do not develop colitis.	 
a, Cd4creUhrf1fl/fl (fl/fl) and control littermate (+/+) mice were maintained under SPF conditions until 
12 weeks of age. Macroscopic observation of colon are shown. b-c, fl/fl and +/+ mice were 
maintained under GF conditions until they were 10 weeks old. Macroscopic observation (b), 
histochemical examination by hematoxylin-eosin (upper) and Alcian blue staining (lower) (c), and 
immunofluorescent images with nuclei counter staining (blue) (d) are shown. Scale bars: 200 µm. 
Data are representative of three independent experiments (total 3 mice per group) with similar results.  
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Figure 2-15 | Histological examination of various peripheral tissues in Cd4CreUhrf1fl/fl mice and 
control littermates	 
The tissue sections from the indicated tissues of 13-16 week-old Cd4CreUhrf1+/+ (+/+) or 
Cd4CreUhrf1fl/fl (fl/fl) mice were stained with hematoxylin-eosin for histological examination. Data 
are representative of three individual mice for each group. Scale bars: 200 µm. 	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Figure 2-16 | Uhrf1-deficiency does not influence development of TH1 and TH17 cells 	 
a-b, Splenic naive CD4+ T cells were cultured under stimulation with anti-CD3 and anti-CD28-
mAbs and IL-12 (a) or IL-1β, IL-6 and TGF-β (b) to induce differentiation into TH1 or TH17 cells, 
respectively. Data are representative of two independent experiments. Error bars: s.d. (n = 3). NS: 
not significant (Mann-Whitney U test). c-f, DNA methylation status on the indicated genes in 
Tconv　 (CD3ε+CD4+CD25-hCD2-) and Treg (CD3ε+CD4+CD25+hCD2+) cells from mesenteric 
lymph nodes of Cd4creUhrf1fl/fl (fl/fl) and control littermate (+/+) mice was analyzed by MeDP-Seq.	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Figure 2-17 | A defect in colonic Treg proliferation is responsible for the development of 
spontaneous colitis in Cd4creUhrf1fl/fl mice	
a, b, Six-week-old Cd4creUhrf1fl/fl mice received hCD2+ or hCD2– cells prepared from CD45.1+ 
congenic Foxp3hCD2 mice. Histological examination and immunofluorescent staining of the colonic 
tissues were performed at 6 weeks post-transfer (a). CD4+ T cells from cLP were characterized by 
flow cytometry (b). Scale bars: 200 µm. Data are representative of two independent experiments 
(total 4 mice per group) with similar results.	
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Figure 2-18 | A model of the Uhrf1-dependent mechanism of colonic Treg expansion in response 
to colonisation by gut microbiota	 
1) Early in life, colonizing bacteria are initially recognized by antigen presenting cells (APC) such as 
dendritic cells, 2) The antigen-loaded APCs evoke an IL-2 response by stimulating Teff cells through 
antigen presentation, 3) IL-2 provides the cue for Tregs to proliferate, and simultaneously upregulates 
Uhrf1 expression in Tregs, 4) Uhrf1 represses the cyclin-dependent kinase inhibitor Cdkn1a via DNA 
methylation to safeguard active proliferation of Tregs, 5) the actively proliferating Tregs become 
functionally mature and in turn prevent excessive immune responses to the colonizing microbiota. 
This model illustrates establishment of gut immune homeostasis based on the reciprocal interaction 
between Tregs and Teff cells. Note that commensal bacteria-derived butyrate facilitates peripheral 
generation, but not proliferation, of Tregs.  	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5 General discussion 
5.1	 Regulation of colonic Treg homeostasis by short chain fatty acids (SCFAs) 
In the first section of this study, we have demonstrated that butyrate, a SCFA, plays a 
critical role in the de novo generation of pTreg cells in the colonic mucosa. In support of this 
notion, administration of butyrylated high-amylose maize starch (HAMSB), which can deliver 
butyrate to the colonic lumen58, remarkably increased the number of colonic Treg cells. In 
addition, Smith et al. reported that oral administration of high concentrations (150 mM) of 
SCFAs—particularly acetate and propionate—were sufficient to enhance the frequency of 
colonic Treg cells in germ-free mice85. Conversely, our in vitro experiments demonstrated 
that butyrate efficiently increased the differentiation of naïve CD4+ T cells into Foxp3+ cells, 
whereas physiological concentrations of propionate and acetate showed moderate or no effects, 
respectively44. The discrepancy between these in vivo and in vitro observations suggest that 
SCFAs increase the number of colonic Treg cells by promoting differentiation, as well as 
through other mechanisms such as regulating the colonic migration of extra-intestinal Treg 
cells33. Indeed, oral administration of propionate upregulates the expression of Gpr15, a colonic 
Treg-specific gut-homing molecule43, on Treg cells85. We suspect that a large portion of orally 
administered SCFAs are absorbed into the portal vein and/or utilized by small intestinal 
epithelium prior to reaching the colonic lumen. Considering that the gut microbiota produces 
SCFAs predominantly in the distal intestine, their oral administration may be inappropriate to 
evaluate the physiological roles of SCFAs locally produced. Alternatively, low fiber diets 
containing acetylated, propionylated, or butyrylated high-amylose maize (HAM) starches are 
suitable to evaluate the biological functions of each SCFA individually. These chemically 
modified starches are resistant to amylolysis in the small intestine and can reach the colonic 
lumen in large quantities. Esterified acids are released by gut microbes, subsequently raising 
SCFA levels within the colonic content. Consistent with the in vitro observations, the frequency 
of colonic Treg cells is significantly increased by diets containing butyrylated starch, whereas 
propionylated or acetylated starches either slightly or failed to induce colonic Treg cells in SPF 
mice44. Taken together, locally produced butyrate plays an essential role in de novo Treg 
differentiation in colonic mucosa, whereas oral administrations of acetate and propionate likely 
mediate the migration of Tregs into the colon via upregulation of Gpr1533. 
Butyrate is well documented to inhibit the activity of class I and IIa histone 
deacetylases (HDACs) among four classes of HDACs. We also observed that butyrate 
selectively inhibited HDAC1 and HDAC2 activity (data not shown). Chromatin 
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immunoprecipitation-sequencing (ChIP-seq) analysis demonstrated that exposure of naïve 
CD4+ T cells to butyrate enhanced the acetylation of histone H3 in the promoter, CNS1, and 
CNS3 regions of the Foxp3 gene locus to induce its expression. These observations indicate 
that butyrate facilitates the accessibility of the Foxp3 promoter and enhancer regions to 
transcriptional regulators. Of note, butyrate affects neither the acetylation nor the expression 
levels of T-bet, GATA3, and RORγt, which are transcription factors involved in TH1, TH2, 
and TH17 differentiation, respectively44. Furthermore, Chang et al. and Arpaia et al. reported 
that butyrate suppressed pro-inflammatory cytokine production by innate immune cells such 
as macrophages and DCs most likely due to HDAC inhibition75,86. However, further 
investigation is required to clarify the molecular mechanisms by which butyrate selectively 
facilitates Foxp3 expression and anti-inflammatory responses through HDAC inhibition. 
SCFAs serve as specific activators of Gpr41, 43, and 109a encoded by Ffar3, Ffar2, 
and Niacr1, respectively4. Gpr43 and Gpr109a are predominantly expressed in	 intestinal 
epithelial cells (IECs) and myeloid cells, such as DCs and granulocytes. In contrast, 
lymphocytes are devoid of both receptors. Although Gpr43 is activated by all three SCFAs, 
Gpr109a is only activated by butyrate87. Singh et al. suggests that Gpr109a activation, a 
receptor for butyrate and niacin, induces Raldh1 expression in DCs to promote the production 
of retinoic acid (RA), leading to the induction of Treg differentiation88. Given that RA also 
contributes in facilitating the expression of gut-homing receptors, such as CCR9 and α4β7 
integrin on lymphocytes89, butyrate may indirectly increase colonic Treg cells by promoting 
their migration.  
Alteration in the composition of commensal bacteria, called dysbiosis, is associated 
with the development of multiple diseases including IBD90. Previous studies reported that the 
frequency of butyrate-producing bacteria is decreased in fecal samples from patients with 
IBD compared with healthy subjects72. Furthermore, butyrate treatment as well as 
administration of butyrate-producing probiotics ameliorate the symptoms of IBD73,91. These 
previous studies together with our data raise the possibility that butyrate may contribute to 
the control of intestinal inflammation. Indeed, intake of butyrylated starches significantly 
ameliorated experimental colitis induced by adoptive transfer of CD4+CD45RBhi T cells into 
Rag1-/- mice lacking T and B cells. Collectively, these findings demonstrate that 
microbe-derived SCFAs, especially butyrate, contribute to the maintenance of gut 
immunological homeostasis by promoting Treg accumulation in the colonic mucosa. 
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5.2	 DNA methylation-dependent control of colonic Treg proliferation 
We here defined that bacterial colonization induces an early IL-2 response within the 
colonic mucosa, which in turn leads to the accumulation of Treg cells, at least partly through 
vigorous proliferation, overwhelming the activation of Teff cells. The local proliferative 
activity of colonic Treg cells was maximal before weaning and gradually decreased with age. 
This suggests that the vigorous proliferation of colonic Treg cells is induced early after birth 
in parallel with the establishment of the commensal microflora. This model is congruent with 
the observation that the expression level of Uhrf1 is much higher in colonic Treg cells from 
2-week-old infant mice compared to those from adult mice. Similarly, Uhrf1 expression by 
colonic Treg cells was upregulated after inoculation of intestinal microflora into GF mice. On 
the other hand, Uhrf1 expression by splenic Treg cells of the same mice remained unchanged 
before and after the inoculation, consistent with the minimal proliferative response in the 
spleen. Thus, the expression level of Uhrf1 is positively correlated with the proliferative 
activity of Treg cells, and Uhrf1 deficiency severely affects local Treg expansion in response 
to bacterial colonization. The data as a whole support our conclusion that local proliferation 
of Treg cells is the major downstream consequence of Uhrf1 expression. Strikingly, the 
ablation of Uhrf1 severely affected suppressive functions of Treg cells. We consider that this 
defect is due to the compromised proliferative response by Uhrf1-deficient Treg cells, 
because proliferating Treg cells express higher levels of functional molecules than the cells in 
the non-proliferative compartment. Therefore, colonic tissue behaves as a privileged site to 
confer functional maturity on Treg cells. Considering that Uhrf1-deficient mice 
spontaneously develop colitis, this immunoregulatory mechanism ensured by 
Uhrf1-dependent Treg proliferation is essential for the establishment of a symbiotic 
host-microbe relationship without inflammation. 
Our data clearly demonstrate that Uhrf1 is an IL-2-responsive molecule. In the 
intestine, both T cells and dendritic cells can produce IL-292,93. We also confirmed that IL-2 
is produced by both T cell and non-T cell populations, among which CD4+ T cells mainly 
contribute to IL-2 production after colonization of commensals (data not shown). We found 
that colonization of the 17-mixture strains of Clostridia from human feces28 drives Tconv 
cells to produce IL-2, which in turn upregulates Uhrf1 in Treg cells, resulting in their active 
proliferation. In our ex vivo experiments, Tconv cells from the 17-mix-associated mice 
produce IL-2 only in the presence of autoclaved 17-mix (data not shown), implying that some 
of the Tconv cells in the 17-mix-associated mice produce IL-2 in an antigen-specific manner. 
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These observations raise the possibility that stimulation of T cells through the TCR with 
bacterial antigens may initiate activation of the IL-2-Uhrf1 pathway.  
Like Uhrf1-deficient mice, mice lacking either IL-2 or one of its receptors (IL-2Rα 
and IL-2Rβ) spontaneously develop chronic colitis due to an excessive response to 
commensal bacteria94,95. Moreover, these mice develop lethal lymphoid hyperplasia and 
autoimmune disorders characterized by hemolytic anemia96,97. Such systemic autoimmune 
disorders were not observed in Uhrf1-deficient mice. Therefore, among many biological 
functions of IL-2, the role of the IL2-Uhrf1 pathway is per se confined to the maintenance of 
gut immune homeostasis. Given that genetic polymorphisms of IL2 and IL2Ra are closely 
associated with the development of human IBD98, our findings may provide molecular insight 
into the pathogenesis of IBD.  
We identified Cdkn1a (encoding p21) as a target molecule for Uhrf1, and showed the 
importance of the Uhrf1-Cdkn1a axis in the proliferation of Treg cells. Cdkn1a plays a vital 
role in controlling proliferation, differentiation and tumorigenesis in many cell types99. 
Cdkn1a transcriptional regulatory mechanisms are not yet fully elucidated, although this 
molecule seems to be regulated via multiple pathways, which may be different among 
various cell types. Kim et al. reported a possible link between Uhrf1 and Cdkn1a in ES cells 
and HeLa cells100. The authors mentioned that Uhrf1 recruits G9a on the Cdkn1a promoter, to 
accumulate the repressive histone modification, H3K9me2. The Cdkn1a gene locus contains 
proximal and distal promoters in which CpG islands and a CpG cluster are present, 
respectively. In intestinal epithelial cells, the proximal promoter is almost completely 
unmethylated; however, the distal promoter are partially methylated, which is negatively 
correlated with Cdkn1a expression101. In agreement with this observation, Uhrf1 deficiency 
leads to aberrant expression of Cdkn1a due to hypomethylation of the distal promoter region 
in Treg cells. It is well documented that TGF-β signaling transactivates Cdkn1a gene 
expression as a canonical pathway102,103. Given that TGF-β, which is abundant in the 
intestinal tissue, is essential for the induction and maintenance of Treg cells, it is conceivable 
that intestinal Treg cells may be continuously under pressure to upregulate Cdkn1a. In this 
context, Uhrf1-dependent CpG methylation may function to prevent the unwanted Cdkn1a 
expression that leads to a disadvantage in Treg cell cycle progression.  
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6 Conclusion 
Over 100 trillion bacteria are present in the human gastrointestinal tract. These 
commensal bacteria have long been appreciated for the benefits they provide to their host. 
Benefits represented by the capacity to metabolize indigestible food ingredients into small 
metabolites that are utilized as nutrients by host cells4. In this study, we showed that 
commensal microbe-derived butyrate influences the epigenetic status of gut CD4+ T cells via 
histone modifications, and thereby upregulates transcription of genes responsible for Treg 
differentiation. Our findings not only link butyrate to commensal microbe-mediated induction 
of functional Treg cells in the colonic mucosa, but also provide scientific evidence on the 
therapeutic application of butyrylated starches in IBD. These observations clearly illustrate 
how a metabolite produced by colonic microbial fermentation mediates the host-microbial 
crosstalk prerequisite for the establishment of gut immune homeostasis.  
In addition, we also identified epigenetic regulator Uhrf1 as a molecule responsible 
for the expansion and functional maturation of colonic Treg cells. We found that commensal 
bacteria-dependent upregulation of Uhrf1 contributed to the maintenance of DNA 
methylation in Cdkn1a promoter region of colonic Treg cells, which leads to vigorous 
proliferation of Treg cells during infancy. Mice with T cell-specific deletion of Uhrf1 
spontaneously developed severe intestinal inflammation due to defect in colonic Treg 
homeostasis. Collectively, these observations provide the first evidence of the significance of 
epigenetic regulation in the maintenance of T-cell-balance, essential for the avoidance of 
chronic intestinal inflammation. 
These two findings suggest that appropriate regulation of epigenetic status in 
intestinal T cells is crucial for the maintenance of gut immunological homeostasis. Therefore, 
it will become more important to investigate the molecular machineries regulating the 
epigenetic status of immune cells, as well as the bioenvironmental factors (e.g., infectious 
agents, cytokines, hormones, diets, stress, and microbial products) that potentially influence 
the epigenome of the multiple types of immune cells. Epigenetic modifications are frequently 
heritable to daughter cells, and their accumulation could cause chronic inflammation, 
autoimmune disorders, and allergic diseases. Further studies on epigenetic modifications in 
immune cells are required for understanding the mechanism by which the immune system is 
controlled by environmental factors and for the development of novel epigenetic therapies in 
diverse immunological disorders. 
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7 Materials and methods 
 
7.1 Section I 
Animal experiments 
Germ-free IQI mice were housed in germ-free isolators in the animal facility of 
RIKEN. Eight-to-ten-week-old male or female germ-free mice were orally inoculated with 
3% (v/v) chloroform-treated murine faecal suspension (CRB)57. Germ-free and 
CRB-associated mice, which were housed in different isolators, were randomly grouped, and 
each group was fed with a g-ray-sterilized CMF chow (Oriental Yeast) as a HFD, or 
AIN93G-fomula diet (Oriental Yeast) as a LFD for 4 weeks. To generate 
B.-thetaiotaomicron-associated mice, male or female germ-free mice of 8–16 weeks of age 
were colonized with a single gavage of 108 colony-forming units of B. thetaiotaomicron, 
JCM 5827T (Japan Collection of Microorganisms). Ten days after the inoculation, 
B.-thetaiotaomicron-associated mice were randomly grouped and each group was fed with 
the diet containing 15% (w/w) HAMS and HAMSB as a substitute for corn starch for 
4 weeks. C57BL/6 mice and Myd88−/− Ticam1−/− mice were purchased from CLEA Japan and 
Oriental Bioservice, respectively. Mice were fed with AIN93G as a control diet for a week, 
and subsequently a diet containing 15% (w/w) HAMS, HAMSA, HAMSP or HAMSB for 
4 weeks. Foxp3-hCD2-hCD52 knock-in (Foxp3hCD2) mice were described previously81. OT-II 
transgenic mice were from the Jackson Laboratory. All animal experiments were performed 
using protocols approved by Animal Studies Committees of RIKEN Yokohama Institute and 
Yokohama City University. Sample size was determined based on published studies using 
similar assays as well as the previous experience of the senior authors. No blinding was done 
for animal studies. 
 
Adoptive transfer of OT-II T cells 
OT-II (Ly5.2) transgenic CD4+ T cells were enriched from the spleen and lymph 
nodes using the IMag Cell Separation System. CD3+ CD4+ CD25− VaD+ cells were sorted 
using FACSAriaII and intravenously transferred into C57BL/6 (Ly5.1) mice. Recipient mice 
were administered 1% ovalbumin in drinking water for 9 days. 
 
Flow cytometry 
The following monoclonal antibodies were conjugated with biotin, FITC, AlexaFluor 
488, phycoerythrin (PE), PerCP-Cy5.5, PE-Cy7, allophycocyanin (APC), AlexaFluor 647, 
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Alexa700, APC-H7, eFluor450, Brilliant Violet 421 or V500 (from BD Bioscience, 
eBioscience or Biolegend): anti-human CD2 (RPA-2.10), anti-mouse CD3e (145-2C11), 
CD4 (GK1.5), CD25 (PC61), CD44 (IM7), CD45R/B220 (RA3-6B2), CD45RB (16A), 
CD62L (MEL-14), CD103 (2E7), Gr1 (RB6-8C5), folate receptor 4, FR4 (eBio12A5), Foxp3 
(FJK-16 s), Helios (22F6), IL-10 (JES5-16E3) and TER119 (TER-119). Biotinylated 
anti-mouse/rat neuropilin-1 polyclonal antibodies were from R&D Systems. 
For intracellular staining of Foxp3 and Helios, lymphocytes were pre-incubated with 
FcgR (CD16/CD32)-blocking monoclonal antibody (93; eBioscience) before staining for 
surface antigens. The cells were then fixed, permeabilized and stained with relevant 
monoclonal antibodies using the Foxp3 staining set (eBioscience) according to the 
manufacturer’s instructions. 
For intracellular IL-10 staining, lamina propria lymphocytes were cultured for 6 h in 
complete medium (RPMI1640 containing 10% FCS, 100 U ml−1 penicillin, 100 mg ml−1 
streptomycin, 55 mM mercaptoethanol and 20 mM HEPES, pH 7.2) supplemented with 
50 ng ml−1 phorbol myristate acetate, 500 ng ml−1 ionomycin, and Golgi Plug (BD 
Bioscience) in 12-well plates. The lymphocytes were then stained with monoclonal 
antibodies against CD3e, CD4, CD25 and FR4, followed by intracellular staining for IL-10 
using a Cytofix/Cytoperm kit (BD Bioscience). Our preliminary experiments demonstrated 
that the colonic CD3e+ CD4+ CD25+ FR4+ population exclusively consists of Foxp3+ cells, 
consistent with a previous report104. The stained samples were analysed using FACSCanto II 
and FACSAria II flow cytometers with DIVA software (BD Biosciences) and FlowJo 
software version 9.3.2 (Tomy Digital Biology). 
 
Preparation of lymphocytes 
Colonic lamina propria lymphocytes were prepared as described previously105. In 
brief, colonic tissues were treated with HBSS (Wako Pure Chemical industries) containing 
1 mM dithiothreitol and 20 mM EDTA at 37 °C for 20 min to remove epithelial cells. The 
tissues were then minced and dissociated with collagenase solution containing 0.5 mg ml−1 
collagenase (Wako Pure Chemical Industries), 0.5mg ml−1 DNase I (Roche Diagnostics), 2% 
FCS, 100 U ml−1 penicillin, 100 mg ml−1 streptomycin and 12.5 mM HEPES, pH 7.2, in 
RPMI 1640 medium (Sigma-Aldrich) at 37 °C for 30 min to obtain single-cell suspensions. 
After filtering, the single-cell suspensions were washed with 2% FCS in RPMI 1640, and 
subjected to Percoll gradient separation. The spleen and mesenteric lymph nodes were 
mechanically disrupted into single-cell suspensions. 
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In vivo EdU-incorporation assay 
To detect proliferating cells in vivo, HAMS- or HAMSB-fed mice received 
intraperitoneal injection of 3 mg EdU in 200 ml PBS, followed by administration of drinking 
water containing 0.8 mg ml−1 EdU for 2 days before the analysis. EdU-incorporated cells in 
cLP were visualized using Click-it EdU Flow cytometry kit (Invitrogen), following the 
manufacturer’s instructions. 
 
Microbiological analysis 
Bacterial genomic DNA was isolated as described previously with some 
modifications106. In brief, faecal samples were lyophilized by using VD-800R lyophilizer 
(TAITEC) for 24 h. Freeze-dried faeces were disrupted with 3.0 mm Zirconia Beads 
(Biomedical Science) by vigorous shaking (1,500 r.p.m. for 10 min) using Shake Master 
(Biomedical Science). Faecal samples (10 mg) were suspended with DNA extraction buffer 
containing 400 ml 10% (w/v) SDS/TE (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) solution, 
400 ml phenol/chloroform/isoamyl alcohol (25:24:1), and 200 ml 3 M sodium acetate. Faeces 
in mixture buffer were further disrupted with 0.1 mm zirconia/silica beads (BioSpec 
Products) by vigorous shaking (1,500 r.p.m. for 10 min) using Shake Master (Biomedical 
Science). After centrifugation at 15,000g for 30 min at room temperature, bacterial genomic 
DNA was purified from the faecal extracts by a phenol/chloroform/isoamyl alcohol method. 
Adequate amounts of bacterial genomic DNA samples were amplified by the SYBR premix 
Ex Taq (TAKARA BIO) with the universal primers or Clostridiales-specific primers for the 
genes encoding the bacterial 16S rRNA sequence107. The results were calculated as the 
quantity relative to the copy number detected in the faeces of conventional mice. 
 
454-barcoded pyrosequencing of 16S rRNA genes 
The V1–V2 region of the 16S rRNA gene was amplified as described elsewhere108. 
Mixed samples were prepared by pooling approximately equal amounts of PCR amplicons 
from each sample and subjected to 454 GS JUNIOR (Roche Applied Science) sequencing 
according to the manufacturer’s instructions. 16S rRNA reads were analysed using 
QIIME(v1.6): fasta, quality files and a mapping file indicating the bar-code sequence 
corresponding to each sample were used as input. The QIIME pipeline takes this input 
information and split reads by samples according to the bar code, and classifies all 3,000 
filter-passed reads of the 16S V1–V2 sequences obtained from each sample into operational 
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taxonomic units on the basis of sequence similarity. It also performs taxonomical 
classification using the RDP-classifier (v2.5)109. The phylogenetic tree was constructed using 
ClustalW 2.0110 with 100 bootstrap iterations. The tree was visualized with iTOL111. 
 
NMR-based metabolomics 
Faecal and caecal metabolites were extracted by gentle shaking with 100 mM 
potassium phosphate buffer containing 90% deuterium oxide and 1 mM sodium 
2,2-dimethyl-2- silapentane-5-sulphonate as the chemical shift reference (d = 0.0 p.p.m.), and 
then analysed by 1H-NMR and 1H, 13C-NMR112,113. PCA and orthogonal partial least squares 
discriminate analysis on the caecal metabolome data were run with the SIMCA-P+ software 
(ver 12.0, Umetrics) 114,115. All NMR experiments were conducted using Bruker DRX-700 
spectrometer equipped with a cryogenically cooled probe. The NMR spectra were processed 
essentially as described116-118. In brief, 1H-NMR data were reduced by subdividing the spectra 
into sequential 0.04 p.p.m. designated regions between 1H chemical shifts of 0.0 to 9.5 p.p.m. 
After exclusion of water resonance, each region was integrated and normalized to the total of 
all resonance integral regions. Metabolite annotations were performed using our standard 
database119,120. 
 
Mass spectrometry 
Organic acid concentrations of caecal contents and colonic tissues were determined by 
gas chromatography–mass spectrometer (GC–MS)121. In brief, 10 mg caecal contents or 
colonic tissues were disrupted using 3 mm zirconia/silica beads (BioSpec Products) and 
homogenized with extraction solution containing 100 ml of internal standard (100 mM 
crotonic acid), 50 ml HCl and 200 µl ether. After vigorous shaking using Shakemaster neo 
(Bio Medical Science) at 1,500 r.p.m. for 10 min, homogenates were centrifuged at 1,000g 
for 10 min and then the top ether layer was collected and transferred into new glass vials. 
Aliquots (80 ml) of the ether extracts were mixed with 16 ml 
N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide (MTBSTFA). The vials were sealed 
tightly, heated at 80 °C for 20 min in a water bath, and then left at room temperature for 48 h 
for derivatization. The derivatized samples were run through a 6890N Network GC System 
(Agilent Technologies) equipped with HP-5MS column (0.25 mm × 30 m × 0.25 mm) and 
5973 Network Mass Selective Detector (Agilent Technologies). Pure helium (99.9999%) was 
used a carrier gas and delivered at a flow rate of 1.2 ml min−1. The head pressure was set at 
14.1 psi with split 20:1. The inlet and transfer line temperatures were 250 and 260 °C, 
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respectively. The following temperature program was used: 60 °C (3 min), 60–120 °C (5 °C 
per min), 120–300 °C (20 °C per min). One microlitre of each sample was injected with a run 
time of 30 min. Organic acid concentrations were quantified by comparing their peak areas 
with the standards. 
 
HPLC analysis of faecal organic acids 
Faecal and caecal organic acids were measured by the internal standard method using 
an HPLC equipped with Shim-pack SCR-102H column (Shimadzu) and an 
electroconductivity detector (CDD-6A, Shimadzu)122. 
 
In vitro cultures 
CD4+ cells were enriched from the spleen and lymph nodes of C57BL/6 mice by a 
negative selection method with the IMag Cell Separation System (BD Bioscience) using a 
mixture of biotinylated monoclonal antibodies against B220, CD8a, CD11c, Gr-1 and 
Ter-119 and Streptavidin Particle Plus-DM (all from BD Bioscience). The enriched CD4+ 
fraction was subjected to cell sorting with FACSAriaII to isolate CD3+ CD4+CD25− CD44lo 
CD62Lhi naive T cells. For Treg cell polarization, naive CD4+ T cells (5 × 105 cells ml−1) 
were stimulated with immobilized anti-CD3 monoclonal antibody (10 mg ml−1) and soluble 
anti-CD28 monoclonal antibody (1 mg ml−1) supplemented with 0.2 ng ml−1 TGF-b1 and 
10 ng ml−1 IL-2 (both from R&D Systems) in the presence or absence of 0.1 mM sodium 
acetate, sodium propionate or sodium butyrate (Sigma-Aldrich) for 1–3 days (Fig. 3). In the 
experiments described in Fig. 2a, b and Supplementary Fig. 7, T cells (5 × 105 cells ml−1) 
were cultured for 3 days and then expanded in complete medium supplemented with TGF-b 
and IL-2 for 2 days followed by analyses. T cells were polarized to TH1, TH2 or TH17 
subtypes in vitro by the addition of the following: 10 ng ml−1 IL-12 (R&D Systems) and 
10 mg ml−1 anti-IL-4 monoclonal antibody (clone 11B11) for TH1 cell polarization; 
10 ng ml−1 IL-4 (R&D Systems) and 10 mg ml−1 anti-IL-12 monoclonal antibody (clone: 
R4-6A2) for TH2 cell polarization; and 40 ng ml−1 IL-6 (R&D Systems) and 0.2 ng ml−1 
TGF-b1, along with 10 mg ml−1 each of anti-IFN-g and anti-IL-4 monoclonal antibodies for 
TH17 cell polarization. IL-2 was added to the medium 48 h after initial stimulation, and T cell 
were cultured for 2 days followed by analyses. 
 
ChIP 
ChIP assays were performed using the MAGnify ChIP system (Invitrogen) according 
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to the manufacturer’s protocol with a few modifications. In brief, 500,000 cells were fixed 
with 1% formaldehyde (room temperature, 10 min) and the reaction was stopped by the 
addition of glycine to a final concentration of 125 mM. Crude nuclei were isolated in SDS 
lysis buffer to obtain the chromatin solution. The chromatin solution was sonicated using a 
focused-ultrasonicator (Covaris) to reduce the chromatin DNA length to approximately 100–
300 base pairs. The acoustic parameters were optimized (Duty cycle: 10%, Intensity: 5, 
Cycle/Burst: 200, 15 cycles) with monitoring the DNA fragment using Agilent 2100 
Bioanalyzer. The sheared chromatin was immunoprecipitated (overnight, 4 °C) with 
magnetic protein A/G beads with immobilized 3 mg of anti-acetyl histone H3 antibody 
(Millipore) or rabbit IgG on a rotating wheel. After extensive washing, immune complexes 
were eluted (55 °C, 30 min) and reverse crosslinking was carried out (65°C, 1 h) in the 
presence of proteinase K. qPCR analysis was performed following magnetic bead-based 
DNA purification. For ChIP-seq library construction, immunoprecipitated DNA fragments 
were ligated with adaptors and amplified by PCR. Amplified libraries were subjected to 
cluster generation and sequencing analysis with the Hiseq 1000 (Illumina). Sequenced reads 
were mapped to the mouse genome (v. mm9) with BOWTIE. Peaks for each population were 
called with MACS with P value threshold of less than 1 × 10−5. The numbers of reads in a 
section were that of total mapped reads and the length of each section. Because butyrate 
treatment globally enhances histone acetylation, total mapped reads may be increased in 
butyrate-treated cells compared to control cells. Therefore, the normalized values within each 
sample were further subjected to cross-sample adjustment on the basis of read counts of the 
four genomic regions around transcription start sites of the housekeeping gene Rpl13a, whose 
histone acetylation status remained unchanged between butyrate-treated and untreated cells 
as confirmed by ChIP-qPCR analysis (data not shown). The normalized reads were calculated 
within fixed base length for upstream and downstream regions, and relative length for genic 
regions. 
 
Gene expression profiling 
Total RNA was extracted by Trizol reagent (Life Technologies) following a standard 
protocol, and subjected to microarray analysis using the GeneChip Mouse Gene 1.0 ST Array 
(Affymetrix). Microarray signals were processed using a standard robust multiarray 
averaging (RMA) algorithm. Observed signals were normalized using quantile normalization 
method and genes that had no significant signals were ignored to reduce noise. 
Butyrate-sensitive transcription factors were selected using annotation provided by Gene 
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Ontology, as they have annotation ‘nucleus (GO:0005634)’ and ‘regulation of transcription, 
DNA-dependent (GO:0006355)’. Their acetylation was represented by the normalized peak 
height of ChIP-seq reads from 4 kb upstream to 4 kb downstream of the transcription start 
site. The distribution of log ratio between control and butyrate treatment could be 
approximated with two Gaussian distributions and fitted curves were determined using 
expectation–maximization algorithm. The threshold value was log2 0.5. 
 
Induction of colitis by adoptive transfer of CD4+ CD45RBhigh T cells 
Colitis was induced in Rag1−/− mice by adoptive transfer of CD4+ CD45RBhigh T cells 
as described previously21. In brief, CD4+ T cells were enriched from splenocytes from 
C57BL/6 mice by IMag Cell Separation System. Enriched CD4+ T cells were labelled with 
FITC-conjugated anti-mouse CD3e (145-2C11), PE-conjugated anti-mouse CD45RB (16A) 
(all from BD Biosciences), and CD3e+ CD4+ CD45RBhigh cells were isolated by cell sorting 
using FACSAria II flow cytometer (BD Biosciences). The Rag1−/− recipients were given 
2 × 105 CD4+ CD45RBhigh T cells via the tail vein, and were euthanized [Author: Note we 
prefer to avoid ‘sacrificed’; ‘euthanized’ is also acceptable if you prefer.] at 6 weeks after 
transfer. For the Treg cell depletion experiment, CD4+ CD45RBhigh T cells from Foxp3hCD2 
reporter mice were adoptively transferred into Rag1−/− mice. The recipient mice were 
received intravenous injection of 1 mg anti-human CD2 monoclonal antibody (35.1) at 4 and 
5 weeks after the transfer. 
 
Histology 
Prefixed colonic tissue sections were deparaffinized, rehydrated and stained with 
haematoxylin and eosin or with Alcian blue-nuclear fast red. The specimens were examined 
histologically for scoring the degree of colitis based on the following criteria: inflammatory 
infiltrates, mucosal hyperplasia and loss of goblet cells. 
 
Immunofluorescent staining 
Immunofluorescent staining of cross-sections of colonic tissues was performed as 
described previously123.  
 
Immunoblotting 
Immunoblotting analysis was performed as described previously124. Antibodies 
against histone H3 (ab1791, Abcam), acetylated histone H3 (06-599, Merck), Stat5 (clone: 
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3H7, Cell Signaling Technology), Smad3 (clone: C67H9, Cell Signaling Technology), 
NFAT1 (4389, Cell Signaling Technology), c-Rel (AF2699, R&D systems) and GAPDH 
(clone: 6C5, MAB374, Merck) were used in this study. 
 
Statistical analyses 
Differences between two or more groups were analysed respectively by the Student’s 
t-test or ANOVA followed by Tukey’s post-hoc test. When variances were not homogeneous, 
the data were analysed by the non-parametrical Mann–Whitney U test or the Kruskal–Wallis 
test followed by the Scheffé test. The body weight changes of the mice fed with or without 
HAMSB were analysed using a two-way repeated measures ANOVA followed by Tukey’s 
test. All statements indicating significant differences show at least a 5% level of probability. 
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7.2 Section II 
 
Animal experiments 
Uhrf1fl/fl mice were generated as depicted in Fig. 2-5, and backcrossed onto a 
C57BL/6 background. To obtain T-cell-specific Uhrf1-deficient mice, Uhrf1fl/fl mice were 
crossed with Cd4Cre transgenic mice (The Jackson Laboratory) and then Foxp3hCD2 knock-in 
mice81. Cd4CreUhrf1fl/flFoxp3hCD2 mice were housed under SPF conditions unless otherwise 
specified. IQI mice were purchased from CLEA Japan Inc. (Tokyo, Japan), and were 
maintained GF in vinyl isolators in the animal facilities of RIKEN IMS and Graduate School 
of Medical Life Science, Yokohama City University. Feces from SPF C57BL/6 mice were 
suspended in PBS or treated with 3% (v/v) chloroform/PBS to obtain CRB, and the aliquots 
were inoculated into GF IQI and Cd4CreUhrf1fl/flFoxp3hCD2 mice by intra-gastric intubation27. 
CRB-treated mice were maintained in the gnotobiotic vinyl isolator for 3-4 weeks. 
Gnotobiotic mice associated with the 17-strain mixture of Clostridia (17-mix) were generated as 
previously described28. 
To inhibit gut homing of extraintesitnal Treg cells43, exGF mice were treated with a 
mixture of mAbs (100 µg each/mouse) against α4 integrin (PS/2, Millipore) and β7 integrin 
(FIB504, Biolegend) or control IgG (Biolegend) on day 3 after bacterial colonization. The 
exGF mice were then subjected to an in vivo EdU incorporation assay as described below. 
Systemic Treg expansion was induced as previously described82. Briefly, SPF 
Cd4CreUhrf1fl/flFoxp3hCD2 mice and control littermates were injected intraperitoneally with the 
IL-2-anti–IL-2 mAb (JES6-1A12, R&D systems) complexes three times on day 0, 1 and 2, 
and proliferation of splenic Treg cells was analyzed on day 5.  
All animal experiments were performed using protocols approved by Animal Studies 
Committees of RIKEN Yokohama Institute, The Institute of Medical Science, The University 
of Tokyo and Graduate School of Medical Life Science, Yokohama City University. 
 
Preparation of lymphocytes 
cLP lymphocytes were prepared as described previously105. Briefly, colonic tissues 
were treated with Hanks' Balanced Salt Solutions (Wako Pure Chemical industries) 
containing 1 mM dithiothreitol and 20 mM EDTA at 37°C for 20 minutes to remove 
epithelial cells. The tissues were then minced and dissociated with collagenase solution 
containing 0.5 mg/mL collagenase (Wako Pure Chemical Industries) and 0.5 mg/mL DNase I 
(Roche Diagnostics), 2% FCS, 100 U/mL penicillin, 100 µg/mL streptomycin, and 12.5 mM 
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HEPES (pH 7.2) in RPMI 1640 medium (Sigma-Aldrich) at 37°C for 30 minutes to obtain 
single-cell suspensions. After filtering, the single-cell suspensions were washed with 2% 
FCS/RPMI1640, and subjected to Percoll gradient separation. The spleen and mesenteric 
lymph nodes were mechanically disrupted into single-cell suspensions. 
For Q-PCR analysis, colonic mononuclear cells was subjected to cell sorting using 
FACSAriaII to isolate CD3e+CD4+CD25+FR4+ or CD3e+CD4+hCD2+ Treg cells, in IQI or 
Foxp3hCD2 reporter mice, respectively. Our preliminary experiments demonstrated that the 
CD3e+CD4+CD25+FR4+ population almost exclusively consists of Foxp3+ cells, consistent 
with a previous report104.  
 
Flow cytometry 
The following mAbs conjugated with biotin, FITC, AlexaFluor488, PE, PerCP-Cy5.5, 
PE-Cy7, APC, AlexaFluor647, AlexaFluor700, APC-H7, eFluor450, Pacific Blue, Brilliant 
Violet 421 or V500 were purchased from BD Bioscience, eBioscience and Biolegend: 
anti-human CD2 (RPA-2.10) and anti-mouse CD3ε (145-2C11), CD4 (GK1.5), CD25 (PC61), 
CD44 (IM7), CD45R/B220 (RA3-6B2), CD62L (MEL-14), Gr1 (RB6-8C5), folate receptor 4 
(FR4) (eBio12A5), Foxp3 (FJK-16s), Helios (22F6), CTLA4 (UC10-4B9), IL-2 (JES6-5H4), 
IL-17A (TC11-18H10.1), IFN-γ (XMG1.2), TNF-α (MP6-XT22), IL-10 (JES5-16E3) and 
TER119 (TER-119). Biotinylated Anti- mouse/rat Neuropilin1 polyclonal antibodies were 
purchased from R&D Systems. 
For intracellular staining of Helios, lymphocytes were pre-incubated with FcγR 
(CD16/CD32)-blocking mAb (93; eBioscience) before staining for surface antigens. The cells 
were then fixed, permeabilized, and stained with relevant mAbs using Foxp3 Staining set 
(eBioscience) according to the manufacturer’s instructions.  
For intracellular staining of cytokines, LP lymphocytes were cultured for 6 h in 
complete medium [RPMI1640 containing 10% FCS, 100 U/ml penicillin, 100 µg/ml 
streptomycin, 55 µM mercaptoethanol and 20 mM HEPES (pH 7.2)] supplemented with 50 
ng/ml PMA, 500 ng/ml ionomycin, and Golgi Plug (BD Bioscience). The lymphocytes were 
then stained with mAbs against CD3e, CD4 and hCD2, followed by intracellular staining for 
IFN-γ, IL-17A, TNFα and IL-10 using a Cytofix/Cytoperm kit (BD Bioscience). The stained 
samples were analyzed using FACSCanto II and FACSAria II flow cytometer with DIVA 
software (BD Biosciences) and FlowJo software version 9.3.2 (Tomy Digital Biology).  
 
In vivo EdU-incorporation assay 
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To detect proliferating cells in vivo, GF and exGF mice received intraperitoneal 
injection of 3 mg EdU in 200 µl PBS, followed by administration of drinking water 
containing 0.8 mg/ml EdU for 2 days before the analysis. EdU-incorporated cells in cLP were 
visualized using the Click-it EdU Flow cytometry kit (Invitrogen), following the 
manufacturer’s instructions.  
 
Gene expression profiling 
Total RNA was extracted by Trizol reagent (Life Technologies) following a standard 
protocol and subjected to microarray analysis using the GeneChip Mouse Genome 430 2.0 
Array (Affymetrix). The obtained data sets were analyzed using GeneSpring GX 11 (Agilent) 
and the Ingenuity pathway analysis (IPA) program (Ingenuity Systems). All microarray data 
have been deposited at GEO under accession number: GSE47818. 
 
Cell culture 
CD3+CD4+CD44loCD62Lhi naive T cells were prepared from the spleen and lymph 
nodes by FACS cell sorting as descried above. Isolated naïve CD4+ T cells (5x105 cells/ml) 
were cultured in complete RPMI1640 medium supplemented with 5 ng/ml TGF-β, 10 ng/ml 
IL-2 (R&D Systems) and anti-CD3-anti-CD28 mAbs-coated Dynabeads (Life Technologies) 
for 3 days to induce differentiation into Foxp3+ cells, and then the differentiated cells were 
expanded in the presence of 0.5 ng/ml TGF-b and 10 ng/ml IL-2 up to an additional 4 days. 
For cell cycle analysis, induced Treg cells were pulsed with 10 µM EdU (Invitrogen) for 2h. 
The cells were stained for EdU and 7-AAD using the Click-iT EdU flow cytometry kit prior 
to the cell-cycle analysis using FACSCanto II and FlowJo software version 9.3.2. 
 
In vitro suppression assays 
CD3e+CD4+hCD2+ and CD3e+CD4+CD62LhiCD44low naive populations were purified 
as Treg and responder cells, respectively, with IMag Cell Separation System followed by 
FACS cell sorting. To prepare antigen-presenting cells (APCs), Thy1.2-depleted splenocytes 
from C57BL/6J mice were irradiated with 20 Gy g-ray. CFSE-labeled responder cells were 
co-cultured with Treg cells at 1:1 ratio in the presence of APCs and anti-CD3 mAb 
(145-2C11, 10 µg/ml) for 3 days.  
 
DNA methylation analysis 
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Genomic DNA samples of CD3e+CD4+hCD2+ cells and CD3e+CD4+hCD2- cells 
derived from mesenteric lymph nodes of male mice were extracted using an AllPrep 
DNA/RNA extraction kit (QIAGEN), fragmented to approximately 200 bp by high-intensity 
focused ultrasound (Covaris), and precipitated using His-tagged MBD1 recombinant 
protein125. After PCR amplification, DNA fragments of the proper size were subjected to 
cluster generation and sequencing analysis with the HiSeq 1000 (Illumina). Sequenced reads 
were mapped to the mouse genome (ver. mm9) with BOWTIE. Peaks for each population 
were called with MACS with p value threshold of less than10−5. The change of DNA 
methylation for a gene between conditions was calculated using the normalized reads mapped 
from 4kb upstream to 4kb downstream of its transcription start site (TSS). TSS regions were 
defined following annotation on Entrez database. 
Bisulfite genomic sequencing of the Cdkn1a promoter were performed as previously 
described78 using Qiagen EpiTect kit. The amplified fragments were cloned using the TOPO 
TA cloning kit (Invitrogen), and subsequently sequenced with the BigDye Terminator Cycle 
Sequencing system (Applied Biosystems) and ABI PRISM 3100 Genetic Analyzer. The PCR 
primers were designed with MethPrimer software 
(http://www.urogene.org/methprimer/index1.html). The sequences of the primer sets are the 
followings: 5’-ATATGTTGGTTTTTGAAGAGGG-3’ and 
5’-ATCCCAAAAAATCCCACTATATC-3’. 
 
Quantitative PCR 
Total RNA was isolated from colonic tissues using the RNeasy mini kit (QIAGEN), 
and was subjected to reverse transcription using the ReverTra Ace kit (TOYOBO), following 
the manufacturer’s instructions. The cDNA samples were amplified with the Thermal Cycler 
Dice Real Time System (TAKARA BIO), SYBR premix Ex Taq (TAKARA BIO) and the 
primer sets specific for mouse genes. The sequences of the primer sets are available upon 
request. 
 
ChIP-Q-PCR analysis 
ChIP assays were performed using the MAGnify ChIP system (Life Technologies, 
NY) as described previously44 with a few modifications. Splenic CD4+CD25+ T cells were 
cultured with Dynabeads Mouse T-Activator CD3-CD28 (Life Technologies) in the presence 
of 10 ng/mL IL-2 and 5 ng/mL TGF-β for 3 days. The cells were allowed to rest for 6 h in 
RPMI 1640 medium (Sigma-Aldrich) containing 0.1% FBS and then were stimulated with or 
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without 100 ng/mL IL-2 for 1.5 h. The cells were fixed with 1% formaldehyde at 37°C in a 
water bath for 10  min, and the reaction was quenched by addition of 125 mM glycine. Crude 
nuclei were isolated in SDS lysis buffer and were sonicated using Microson (Misonix, NY) 
and then a focused-ultrasonicator (Covaris S220, Covaris, MA) to obtain chromatin 
fragments with approximately 100–700  bp DNA length. The acoustic parameters were 
optimized as follows: Duty cycle: 5%, Intensity: 140 watts, Cycle/Burst: 200, 5 minute. After 
evaluation of the sample quality using the Agilent 2100 Bioanalyzer (Agilent, CA), the 
sheared chromatin samples were immunoprecipitated (overnight, 4  °C) using magnetic 
protein A/G beads immobilized with anti-Stat5 antibodies (Cell Signaling, #9363) or rabbit 
IgG under gentle rotation. After extensive washing, immune complexes were eluted at 55  °C 
for 30  min, and treated with proteinase K at 65°C for 1  h to reverse cross-linking. After 
extraction of DNA, Q-PCR analysis was performed using a specific primer set for the 
promoter region of Uhrf1: 5’-TCCCTTTCTCCTCTCCCAGG–3’ and 5’- 
CTGCCGGCTATGCTCACTTT- 3’.   
 
Transfection of siRNA 
Transfection of siRNA was performed using Amaxa Nucleofector kit (RONZA, Basel, 
Switzerland) according to the manufacturer’s protocol with minor modifications. Briefly, 
four micrograms of negative control siRNA or pooled siRNAs targeting Cdkn1a conjugated 
with Hilyte 488 (Nippon gene, Toyama, Japan) were added to the Nucleofector solution 
containing one million cells followed by electroporation (Program: X-001). Cell cycle 
analysis in cells harboring Hilyte 488 was performed using Hoechst 33342, a cell permeable 
DNA binding dye, 24 h after the electroporation. The transfection efficiency was 
approximately 10-15%. The sequences of the Cdkn1a-specific siRNAs are the followings: 
5’-GUUGCGCCGUGAUUGCGAU-3’, 5’-CCAGCCUGACAGAUUUCUA-3’ and 
5’-GAACGGUGGAACUUUGACU-3’. 
 
Immunoblot analysis 
For immunoblot analysis, whole-cell extracts were prepared in RIPA lysis buffer 
containing a cocktail of protease inhibitors (Nacalai Tesque). Equal amounts of cell lysate 
were separated by 5-20% gradient SDS-PAGE gels (Biorad). After transfer, proteins on the 
Immobilon-P membranes (Millipore) were probed using the following primary antibodies: 
mAb for Cdkn1a (SX118, BD Pharmingen) and GAPDH (6C5, Santacruz), and polyclonal 
antibodies for Uhrf1 (M-132, Santacruz), together with the secondary HRP-conjugated 
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secondary antibodies (Cell Signaling Technology). The specific binding of the antibodies was 
visualized by an enhanced chemiluminescence detection system (Nacalai Tesque) and a 
LAS-3000 luminescent image analyzer (Fuji Film). 
 
Histology 
Prefixed colonic tissue sections were deparaffinised, rehydrated and stained with	 
either hematoxylin-eosin or Alcian blue-nuclear fast red. The specimens were histologically 
examined	 for scoring the degree of colitis based on the following criteria: inflammatory 
infiltrates, mucosal hyperplasia and loss of goblet cells. 
 
Adoptive transfer experiments 
Experimental colitis was induced in Rag1–/– mice by adoptive transfer of 
CD4+CD25-CD45RBhigh T cells as described previously67. Briefly, CD4+ T cells were 
enriched from splenocytes of C57BL/6 mice using the IMag Cell Separation System. 
Enriched CD4+ T cells were labeled with FITC-conjugated anti-mouse CD3e (145-2C11), 
PE-conjugated anti-mouse CD45RB (16A) (all from BD Biosciences), and 
CD3e+CD4+CD45RBhigh cells were isolated by cell sorting using FACSAria II flow 
cytometer (BD Biosciences). The Rag1–/– recipients were given 1×105 
CD4+CD25-CD45RBhigh T cells via the tail vein, and were analyzed at 6 weeks after transfer. 
In the experiment described in Fig. 2-7, CD4+CD25+ T cells from Cd4CreUhrf1fl/fl or 
CD4CreUhrf1+/+ mice (8 × 104 cells per mouse) together with CD4+CD25-CD45RBhigh T cells 
from CD45.1+ C57BL/6 mice (1 × 105 per mouse) were co-transferred to Rag1–/– recipients.  
In the experiment described in Fig. 2-17, CD4+hCD2+ or hCD2- T cells from the 
spleen and peripheral lymph nodes of Foxp3hCD2 mice (2 × 106 cells per mouse) were 
intravenously injected into 4-5 week-old Cd4CreUhrf1fl/flFoxp3hCD2 mice. The recipient mice 
were analyzed for colitis development at 12 weeks old.  
 
Generation of mixed bone marrow chimeras 
Bone marrow cells isolated from femora of wild-type (CD45.1+; 1 x 106 cells per 
mouse) and Cd4CreUhrf1fl/fl or +/+ mice (CD45.2+; 1 x 107 cells per mouse) were injected 
intravenously into Rag1–/– mice irradiated with 8-Gy g-ray prior to the injection. Six weeks 
later, cLP of the recipient mice was analyzed by flow cytometry. 
 
Immunofluorescent staining 
Epigenetic modifications and immune regulation by gut microbiota 
Yuuki OBATA 
 
 88 
Immunofluorescent staining of cross-sections of colonic tissues was performed as 
described previously123. 
 
Statistical analysis 
Differences between two or more groups were analyzed respectively by the Student's 
t-test or the one-way analysis of variance test (ANOVA) followed by Tukey’s test. When 
variances were not homogeneous, the data were analyzed by the non-parametrical 
Mann-Whitney U test or the Kruskal-Wallis test followed by the Scheffé test.  
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